{
    "paper_id": "PMC7115613",
    "metadata": {
        "title": "Synthetic approaches, structure activity relationship and biological applications for pharmacologically attractive pyrazole/pyrazoline\u2013thiazolidine-based hybrids",
        "authors": [
            {
                "first": "Dmytro",
                "middle": [],
                "last": "Havrylyuk",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Olexandra",
                "middle": [],
                "last": "Roman",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Roman",
                "middle": [],
                "last": "Lesyk",
                "suffix": "",
                "email": "dr_r_lesyk@org.lviv.net",
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "Pharmacophore hybrid approach is a current concept in drug design and development to produce molecules with improved affinity and efficacy. There are some reviews dealing with the concept of molecular hybridization and the promises/challenges associated with these hybrid molecules along with recent advances on anticancer hybrids [1], [2], [3]. Various heteroaryl based hybrids in particular isatin and coumarins [3] or indoline-thiazolidinones [4] have been recently reviewed as conjugates with remarkable inhibitory potential.",
            "cite_spans": [
                {
                    "start": 331,
                    "end": 334,
                    "mention": "[1]",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 336,
                    "end": 339,
                    "mention": "[2]",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 341,
                    "end": 344,
                    "mention": "[3]",
                    "ref_id": "BIBREF28"
                },
                {
                    "start": 414,
                    "end": 417,
                    "mention": "[3]",
                    "ref_id": "BIBREF28"
                },
                {
                    "start": 446,
                    "end": 449,
                    "mention": "[4]",
                    "ref_id": "BIBREF39"
                }
            ],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "Design of new drug-like small molecules based on the pharmacologically attractive scaffolds of thiazolidine (4-thiazolidinone) [5], [6], [7], [8], [9], [10] and pyrazole or pyrazoline [11], [12], [13], [14], [15] is a reasonable and promising direction in modern medicinal chemistry. The chemical approaches for the synthesis of thiazolidinone- and pyrazole-based derivatives and their pharmacological activity were described in a numerous reviews [5], [6], [7], [8], [9], [10], [11], [12]. However, the pyrazole/pyrazoline\u2013thiazolidine-based conjugates as biologically active compounds are poorly reviewed in the context of pharmacophore hybrid approach.",
            "cite_spans": [
                {
                    "start": 127,
                    "end": 130,
                    "mention": "[5]",
                    "ref_id": "BIBREF50"
                },
                {
                    "start": 132,
                    "end": 135,
                    "mention": "[6]",
                    "ref_id": "BIBREF61"
                },
                {
                    "start": 137,
                    "end": 140,
                    "mention": "[7]",
                    "ref_id": "BIBREF72"
                },
                {
                    "start": 142,
                    "end": 145,
                    "mention": "[8]",
                    "ref_id": "BIBREF83"
                },
                {
                    "start": 147,
                    "end": 150,
                    "mention": "[9]",
                    "ref_id": "BIBREF94"
                },
                {
                    "start": 152,
                    "end": 156,
                    "mention": "[10]",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 184,
                    "end": 188,
                    "mention": "[11]",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 190,
                    "end": 194,
                    "mention": "[12]",
                    "ref_id": "BIBREF9"
                },
                {
                    "start": 196,
                    "end": 200,
                    "mention": "[13]",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 202,
                    "end": 206,
                    "mention": "[14]",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 208,
                    "end": 212,
                    "mention": "[15]",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 448,
                    "end": 451,
                    "mention": "[5]",
                    "ref_id": "BIBREF50"
                },
                {
                    "start": 453,
                    "end": 456,
                    "mention": "[6]",
                    "ref_id": "BIBREF61"
                },
                {
                    "start": 458,
                    "end": 461,
                    "mention": "[7]",
                    "ref_id": "BIBREF72"
                },
                {
                    "start": 463,
                    "end": 466,
                    "mention": "[8]",
                    "ref_id": "BIBREF83"
                },
                {
                    "start": 468,
                    "end": 471,
                    "mention": "[9]",
                    "ref_id": "BIBREF94"
                },
                {
                    "start": 473,
                    "end": 477,
                    "mention": "[10]",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 479,
                    "end": 483,
                    "mention": "[11]",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 485,
                    "end": 489,
                    "mention": "[12]",
                    "ref_id": "BIBREF9"
                }
            ],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "The recent synthetic studies of pyrazole\u2013thiazolidines and related hybrids and biological investigations for their antitumor, antimicrobial, antiviral, antiparasitic, anti-inflammatory activities allowed to identify the promising drug-like compounds. Thus, the pyrazole\u2013thiazolidinones/thiazoles have been patented as inhibitors of necroptosis [16], VHR protein tyrosine phosphatase inhibitors [17], Pin1-modulating compounds [18], compounds for modulating RNA-binding proteins [19] and activators of pro-apoptotic BAX [20]. In addition, the pyrazole\u2013thiazolidinone hybrids have been studied for their possibility to inhibit the TNF-\u03b1\u2013TNFRc1 interaction [21], as inhibitors of histone acetyltransferases [22] and inhibitors of COX [31], [39] and ADAMTS-5 enzymes [83]. Therefore, the purpose of this review is to summarize the data about the synthesis and biological activity of heterocyclic systems with thiazolidine and pyrazole/pyrazoline fragments in molecules. The most promising pyrazole\u2013thiazolidinone/thiazole hybrids and target heterocycles that have been reviewed as fragments of hybrid molecules are depicted in Fig. 1\n.",
            "cite_spans": [
                {
                    "start": 344,
                    "end": 348,
                    "mention": "[16]",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 394,
                    "end": 398,
                    "mention": "[17]",
                    "ref_id": "BIBREF14"
                },
                {
                    "start": 426,
                    "end": 430,
                    "mention": "[18]",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 478,
                    "end": 482,
                    "mention": "[19]",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 519,
                    "end": 523,
                    "mention": "[20]",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 654,
                    "end": 658,
                    "mention": "[21]",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 704,
                    "end": 708,
                    "mention": "[22]",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 731,
                    "end": 735,
                    "mention": "[31]",
                    "ref_id": "BIBREF30"
                },
                {
                    "start": 737,
                    "end": 741,
                    "mention": "[39]",
                    "ref_id": "BIBREF38"
                },
                {
                    "start": 763,
                    "end": 767,
                    "mention": "[83]",
                    "ref_id": "BIBREF87"
                }
            ],
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 1123,
                    "end": 1129,
                    "mention": "Fig. 1",
                    "ref_id": "FIGREF0"
                }
            ]
        },
        {
            "text": "The reviewed hybrids were classified as 2-, 3- and 5-pyrazole/pyrazoline-substituted thiazolidines based on linkage of target heterocyclic cores. The basic approaches for the synthesis of mentioned derivatives provide a combination of two \u201csmall\u201d molecules in aminolysis reactions, acylation and Knoevenagel procedure or heterocyclization of monocyclic compounds via the [2+3]-cyclization reaction yielding the series of non-condensed bicyclic systems.",
            "cite_spans": [],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "Detailed biological activity evaluation of pyrazoline\u2013thiazolidinone conjugates 1.2\u20131.7 and pyrazoline\u2013thiazoles 1.8, 1.9 (Fig. 2\n), synthesized via the [2+3]-cyclocondensation of 4,5-dihydropyrazole-1-carbothioamides 1.1 as S,N-binucleophiles in reactions with equivalents of dielectrophilic synthon [C2]2+, allowed to identify compounds with antimicrobial [23], [24], [25], [26], [27], [28], antiviral [29], [30], anti-inflammatory [31], antitumor [32], [33], [34], [35] and insecticidal [36] activities. For synthesis of target derivatives \u03b1-halogenocarboxylic acids [31], [33] and their ethyl esters [23], [24], [25], [26], [27], [28], [29], [35], [36], maleic anhydride [30], maleimides [30], [38], \u03b2-aroylacrylic acids [30], dimethyl acetylenedicarboxylate [37], bromoacetophenones [23], [24], [28], [29], [35] and ethyl 4-chloroacetoacetate [35] were used as equivalents of dielectrophilic synthon [C2]2+.",
            "cite_spans": [
                {
                    "start": 358,
                    "end": 362,
                    "mention": "[23]",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 364,
                    "end": 368,
                    "mention": "[24]",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 370,
                    "end": 374,
                    "mention": "[25]",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 376,
                    "end": 380,
                    "mention": "[26]",
                    "ref_id": "BIBREF24"
                },
                {
                    "start": 382,
                    "end": 386,
                    "mention": "[27]",
                    "ref_id": "BIBREF25"
                },
                {
                    "start": 388,
                    "end": 392,
                    "mention": "[28]",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 404,
                    "end": 408,
                    "mention": "[29]",
                    "ref_id": "BIBREF27"
                },
                {
                    "start": 410,
                    "end": 414,
                    "mention": "[30]",
                    "ref_id": "BIBREF29"
                },
                {
                    "start": 434,
                    "end": 438,
                    "mention": "[31]",
                    "ref_id": "BIBREF30"
                },
                {
                    "start": 450,
                    "end": 454,
                    "mention": "[32]",
                    "ref_id": "BIBREF31"
                },
                {
                    "start": 456,
                    "end": 460,
                    "mention": "[33]",
                    "ref_id": "BIBREF32"
                },
                {
                    "start": 462,
                    "end": 466,
                    "mention": "[34]",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 468,
                    "end": 472,
                    "mention": "[35]",
                    "ref_id": "BIBREF34"
                },
                {
                    "start": 490,
                    "end": 494,
                    "mention": "[36]",
                    "ref_id": "BIBREF35"
                },
                {
                    "start": 570,
                    "end": 574,
                    "mention": "[31]",
                    "ref_id": "BIBREF30"
                },
                {
                    "start": 576,
                    "end": 580,
                    "mention": "[33]",
                    "ref_id": "BIBREF32"
                },
                {
                    "start": 604,
                    "end": 608,
                    "mention": "[23]",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 610,
                    "end": 614,
                    "mention": "[24]",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 616,
                    "end": 620,
                    "mention": "[25]",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 622,
                    "end": 626,
                    "mention": "[26]",
                    "ref_id": "BIBREF24"
                },
                {
                    "start": 628,
                    "end": 632,
                    "mention": "[27]",
                    "ref_id": "BIBREF25"
                },
                {
                    "start": 634,
                    "end": 638,
                    "mention": "[28]",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 640,
                    "end": 644,
                    "mention": "[29]",
                    "ref_id": "BIBREF27"
                },
                {
                    "start": 646,
                    "end": 650,
                    "mention": "[35]",
                    "ref_id": "BIBREF34"
                },
                {
                    "start": 652,
                    "end": 656,
                    "mention": "[36]",
                    "ref_id": "BIBREF35"
                },
                {
                    "start": 692,
                    "end": 696,
                    "mention": "[30]",
                    "ref_id": "BIBREF29"
                },
                {
                    "start": 698,
                    "end": 702,
                    "mention": "[38]",
                    "ref_id": "BIBREF37"
                },
                {
                    "start": 725,
                    "end": 729,
                    "mention": "[30]",
                    "ref_id": "BIBREF29"
                },
                {
                    "start": 763,
                    "end": 767,
                    "mention": "[37]",
                    "ref_id": "BIBREF36"
                },
                {
                    "start": 788,
                    "end": 792,
                    "mention": "[23]",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 794,
                    "end": 798,
                    "mention": "[24]",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 800,
                    "end": 804,
                    "mention": "[28]",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 806,
                    "end": 810,
                    "mention": "[29]",
                    "ref_id": "BIBREF27"
                },
                {
                    "start": 812,
                    "end": 816,
                    "mention": "[35]",
                    "ref_id": "BIBREF34"
                },
                {
                    "start": 848,
                    "end": 852,
                    "mention": "[35]",
                    "ref_id": "BIBREF34"
                }
            ],
            "section": "Synthetic approaches for 4-thiazolidinone-based hybrids with pyrazole/pyrazoline fragments in position 2",
            "ref_spans": [
                {
                    "start": 123,
                    "end": 129,
                    "mention": "Fig. 2",
                    "ref_id": "FIGREF11"
                }
            ]
        },
        {
            "text": "Three-component one-pot reaction that includes [2+3]-cyclocondensation of 4,5-dihydropyrazole-1-carbotioamides 1.1 with chloroacetic acid and the further Knoevenagel reaction with aromatic aldehydes [33], [34] and isatin derivatives [32] is an effective approach for design of new anticancer agents among the pyrazoline\u2013thiazolidinones 1.10, 1.11 (Fig. 3\n).",
            "cite_spans": [
                {
                    "start": 199,
                    "end": 203,
                    "mention": "[33]",
                    "ref_id": "BIBREF32"
                },
                {
                    "start": 205,
                    "end": 209,
                    "mention": "[34]",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 233,
                    "end": 237,
                    "mention": "[32]",
                    "ref_id": "BIBREF31"
                }
            ],
            "section": "Synthetic approaches for 4-thiazolidinone-based hybrids with pyrazole/pyrazoline fragments in position 2",
            "ref_spans": [
                {
                    "start": 348,
                    "end": 354,
                    "mention": "Fig. 3",
                    "ref_id": "FIGREF22"
                }
            ]
        },
        {
            "text": "The reaction between pyrazolyl-imines [39], [40] or pyrazolyl-hydrazones [41] and thioglycolic acid or its esters is widely used approach for the synthesis of 4-thiazolidinone conjugates 1.12, 1.13 with pyrazole moiety in position 2. A. Khodairy proposed a synthesis of 2-substituted 4-thiazolidinone with benzopyrano[2,3-c]pyrazol-3-one fragment 1.14, using N-cyanoacetyl-benzopyranopyrazolone [42] as a starting compound (Fig. 4\n).",
            "cite_spans": [
                {
                    "start": 38,
                    "end": 42,
                    "mention": "[39]",
                    "ref_id": "BIBREF38"
                },
                {
                    "start": 44,
                    "end": 48,
                    "mention": "[40]",
                    "ref_id": "BIBREF40"
                },
                {
                    "start": 73,
                    "end": 77,
                    "mention": "[41]",
                    "ref_id": "BIBREF41"
                },
                {
                    "start": 395,
                    "end": 399,
                    "mention": "[42]",
                    "ref_id": "BIBREF42"
                }
            ],
            "section": "Synthetic approaches for 4-thiazolidinone-based hybrids with pyrazole/pyrazoline fragments in position 2",
            "ref_spans": [
                {
                    "start": 424,
                    "end": 430,
                    "mention": "Fig. 4",
                    "ref_id": "FIGREF33"
                }
            ]
        },
        {
            "text": "Another direction for synthesis of pyrazole-substituted thiazoline 1.16 (Fig. 5\n) was realized by the creation of pyrazole moiety via the reaction between 5-fluoro-2-hydrazino-4-hydroxy-4,5-bis(trifluoromethyl)-1,3-thiazoline 1.15 with acetoacetone [43], [44].",
            "cite_spans": [
                {
                    "start": 249,
                    "end": 253,
                    "mention": "[43]",
                    "ref_id": "BIBREF43"
                },
                {
                    "start": 255,
                    "end": 259,
                    "mention": "[44]",
                    "ref_id": "BIBREF44"
                }
            ],
            "section": "Synthetic approaches for 4-thiazolidinone-based hybrids with pyrazole/pyrazoline fragments in position 2",
            "ref_spans": [
                {
                    "start": 73,
                    "end": 79,
                    "mention": "Fig. 5",
                    "ref_id": "FIGREF44"
                }
            ]
        },
        {
            "text": "A broad group of pyrazole\u2013thiazolidinone derivatives exemplified by 2-imino-4-thiazolidinones (pseudothiohydantoines) 1.18, 1.19 were synthesized via [2+3]-cyclocondensation of pyrazole substituted asymmetric bis-thioureas 1.17 as S,N-binucleophiles with some equivalents of dielectrophilic synthon [C2]2+ (ethyl 2-chloroacetate [45], [46], dimethyl acetylenedicarboxylate [47]). Simultaneously, bioisosteric pyrazolyl-2-iminothiazolidines 1.20\n[46] were obtained by reaction of thioureas 1.17 with \u03b1-bromoacetophenones (Fig. 6\n).",
            "cite_spans": [
                {
                    "start": 329,
                    "end": 333,
                    "mention": "[45]",
                    "ref_id": "BIBREF45"
                },
                {
                    "start": 335,
                    "end": 339,
                    "mention": "[46]",
                    "ref_id": "BIBREF46"
                },
                {
                    "start": 373,
                    "end": 377,
                    "mention": "[47]",
                    "ref_id": "BIBREF47"
                },
                {
                    "start": 445,
                    "end": 449,
                    "mention": "[46]",
                    "ref_id": "BIBREF46"
                }
            ],
            "section": "Synthetic approaches for 4-thiazolidinone-based hybrids with pyrazole/pyrazoline fragments in position 2",
            "ref_spans": [
                {
                    "start": 521,
                    "end": 527,
                    "mention": "Fig. 6",
                    "ref_id": "FIGREF50"
                }
            ]
        },
        {
            "text": "Aiming to search for new anticancer or antimicrobial compounds among pyrazole\u2013thiazolidinone conjugates the pyrazole-sulfonyl-thioureas 1.21 were used as starting materials. The reaction between compounds 1.21 and ethyl 2-chloroacetate or \u03b1-bromoacetophenone resulted in formation of the corresponding pyrazole\u2013thiazolidinones 1.22 and pyrazole-thiazolidines 1.23 with sulfonylimine linker group [48], [49], [50], [51], [52], [53] (Fig. 7\n).",
            "cite_spans": [
                {
                    "start": 396,
                    "end": 400,
                    "mention": "[48]",
                    "ref_id": "BIBREF48"
                },
                {
                    "start": 402,
                    "end": 406,
                    "mention": "[49]",
                    "ref_id": "BIBREF49"
                },
                {
                    "start": 408,
                    "end": 412,
                    "mention": "[50]",
                    "ref_id": "BIBREF51"
                },
                {
                    "start": 414,
                    "end": 418,
                    "mention": "[51]",
                    "ref_id": "BIBREF52"
                },
                {
                    "start": 420,
                    "end": 424,
                    "mention": "[52]",
                    "ref_id": "BIBREF53"
                },
                {
                    "start": 426,
                    "end": 430,
                    "mention": "[53]",
                    "ref_id": "BIBREF54"
                }
            ],
            "section": "Synthetic approaches for 4-thiazolidinone-based hybrids with pyrazole/pyrazoline fragments in position 2",
            "ref_spans": [
                {
                    "start": 432,
                    "end": 438,
                    "mention": "Fig. 7",
                    "ref_id": "FIGREF51"
                }
            ]
        },
        {
            "text": "Another approach for the synthesis of pyrazole derivatives of pseudothiohydantoin 1.26 was suggested by B. Insuasty et al. [54]. The synthesis of target compounds was carried out via aminolysis of 5-arylidene-2-thioxo-4-thiazolidinones (5-arylidenerhodanines) 1.24 by 4,5-diaminopyrazoles 1.25 (Fig. 8\n).",
            "cite_spans": [
                {
                    "start": 123,
                    "end": 127,
                    "mention": "[54]",
                    "ref_id": "BIBREF55"
                }
            ],
            "section": "Synthetic approaches for 4-thiazolidinone-based hybrids with pyrazole/pyrazoline fragments in position 2",
            "ref_spans": [
                {
                    "start": 295,
                    "end": 301,
                    "mention": "Fig. 8",
                    "ref_id": "FIGREF52"
                }
            ]
        },
        {
            "text": "A row of 2-pyrazolyl-hydrazone\u2013thiazolidinones 1.28\u20131.30 was synthesized via [2+3]-cyclocondensation of thiosemicarbazones 1.27 with \u03b1-halogenocarboxylic acids derivatives or maleic anhydride [55], [56], [57], [58], [59], [60]. The pyrazole with bioisosteric 2-thiohydantoin 1.31\n[61] and thiazolidine 1.32\n[55], [56], [57], [58], [59], [60] fragments were obtained by reaction of thiosemicarbazones 1.27 with chloroacetic acid in pyridine or \u03b1-bromoacetophenone. However, the reaction of thiosemicarbazones 1.27 with acetic anhydride or iron chloride was accompanied by the formation of pyrazole\u2013thiadiazole derivatives 1.33, 1.34\n[56] (Fig. 9\n).",
            "cite_spans": [
                {
                    "start": 192,
                    "end": 196,
                    "mention": "[55]",
                    "ref_id": "BIBREF56"
                },
                {
                    "start": 198,
                    "end": 202,
                    "mention": "[56]",
                    "ref_id": "BIBREF57"
                },
                {
                    "start": 204,
                    "end": 208,
                    "mention": "[57]",
                    "ref_id": "BIBREF58"
                },
                {
                    "start": 210,
                    "end": 214,
                    "mention": "[58]",
                    "ref_id": "BIBREF59"
                },
                {
                    "start": 216,
                    "end": 220,
                    "mention": "[59]",
                    "ref_id": "BIBREF60"
                },
                {
                    "start": 222,
                    "end": 226,
                    "mention": "[60]",
                    "ref_id": "BIBREF62"
                },
                {
                    "start": 280,
                    "end": 284,
                    "mention": "[61]",
                    "ref_id": "BIBREF63"
                },
                {
                    "start": 307,
                    "end": 311,
                    "mention": "[55]",
                    "ref_id": "BIBREF56"
                },
                {
                    "start": 313,
                    "end": 317,
                    "mention": "[56]",
                    "ref_id": "BIBREF57"
                },
                {
                    "start": 319,
                    "end": 323,
                    "mention": "[57]",
                    "ref_id": "BIBREF58"
                },
                {
                    "start": 325,
                    "end": 329,
                    "mention": "[58]",
                    "ref_id": "BIBREF59"
                },
                {
                    "start": 331,
                    "end": 335,
                    "mention": "[59]",
                    "ref_id": "BIBREF60"
                },
                {
                    "start": 337,
                    "end": 341,
                    "mention": "[60]",
                    "ref_id": "BIBREF62"
                },
                {
                    "start": 632,
                    "end": 636,
                    "mention": "[56]",
                    "ref_id": "BIBREF57"
                }
            ],
            "section": "Synthetic approaches for 4-thiazolidinone-based hybrids with pyrazole/pyrazoline fragments in position 2",
            "ref_spans": [
                {
                    "start": 638,
                    "end": 644,
                    "mention": "Fig. 9",
                    "ref_id": "FIGREF53"
                }
            ]
        },
        {
            "text": "Pyrazole-substituted thiosemicarbazides 1.35 were used for synthesis of the pyrazole\u2013thiazolidinones 1.36 with carbohydrazide linker group [62], [63]. The three-component one-pot reaction between thiosemicarbazides 1.35, chloroacetic acid and aromatic aldehydes accompanied by formation of the corresponding 5-arylidene-4-thiazolidinones 1.37\n[63], [64]. The modification of 1.35 in sulfuric acid medium gave pyrazole\u2013thiadiazole 1.38\n[64]. The reaction of compounds 1.35 with \u03b1-bromoacetophenones was accompanied by the formation of corresponding pyrazole-thiazolidine conjugates 1.39\n[62], [63], [64] (Fig. 10\n).",
            "cite_spans": [
                {
                    "start": 139,
                    "end": 143,
                    "mention": "[62]",
                    "ref_id": "BIBREF64"
                },
                {
                    "start": 145,
                    "end": 149,
                    "mention": "[63]",
                    "ref_id": "BIBREF65"
                },
                {
                    "start": 343,
                    "end": 347,
                    "mention": "[63]",
                    "ref_id": "BIBREF65"
                },
                {
                    "start": 349,
                    "end": 353,
                    "mention": "[64]",
                    "ref_id": "BIBREF66"
                },
                {
                    "start": 435,
                    "end": 439,
                    "mention": "[64]",
                    "ref_id": "BIBREF66"
                },
                {
                    "start": 586,
                    "end": 590,
                    "mention": "[62]",
                    "ref_id": "BIBREF64"
                },
                {
                    "start": 592,
                    "end": 596,
                    "mention": "[63]",
                    "ref_id": "BIBREF65"
                },
                {
                    "start": 598,
                    "end": 602,
                    "mention": "[64]",
                    "ref_id": "BIBREF66"
                }
            ],
            "section": "Synthetic approaches for 4-thiazolidinone-based hybrids with pyrazole/pyrazoline fragments in position 2",
            "ref_spans": [
                {
                    "start": 604,
                    "end": 611,
                    "mention": "Fig. 10",
                    "ref_id": "FIGREF1"
                }
            ]
        },
        {
            "text": "Synthesis of 2-diazole-substituted 4-thiazolidinones was achieved via the [2+3]-cyclocondensation of the pyrazole-based asymmetric thioureas 1.17 as S,N-binucleophiles (see Fig. 6). At the same time, the numerous papers represent the data about obtaining of 4-thiazolidinones with diazole moiety in 3 position (compound 2.1, Fig. 11\n), in particular via the reaction of thioureas with ethylchloroacetate [65].",
            "cite_spans": [
                {
                    "start": 404,
                    "end": 408,
                    "mention": "[65]",
                    "ref_id": "BIBREF67"
                }
            ],
            "section": "The main methods for synthesis of 4-thiazolidinones with pyrazole/pyrazoline moiety in position 3",
            "ref_spans": [
                {
                    "start": 173,
                    "end": 179,
                    "mention": "Fig. 6",
                    "ref_id": "FIGREF50"
                },
                {
                    "start": 325,
                    "end": 332,
                    "mention": "Fig. 11",
                    "ref_id": "FIGREF2"
                }
            ]
        },
        {
            "text": "The dithiocarbamate method of 2-thioxo-4-thiazolidinones (rhodanines) synthesis is a convenient and often used variant of the synthesis of 4-thiazolidinone derivatives based on the [2+3]-cyclocondensation [5]. R.M. Mohareb et al. had successfully applied the dithiocarbamate method for the synthesis of 3-(pyrazol-5-yl)-2-thioxo-4-thiazolidinone via two-stage process based on the reaction between 3-phenyl-5-aminopyrazole 2.2 and carbon disulfide in an alkaline medium and subsequent cyclization with ethyl 2-bromoacetate [66]. The presence of the methylene group in the position 5 of thiazolidine cycle allowed the authors to carry out the structural modification of pyrazole\u2013thiazolidinone 2.3 in the Knoevenagel reaction (ethanol medium, catalyst \u2013 piperidine) and diazotization to get the 5-substituted derivatives 2.4, 2.5. Starting from rhodanine 2.3 the alternative methods for the synthesis of condensed pyrano[2,3-d]thiazole system 2.6 with pyrazole moiety in position 3 were proposed, namely the reaction of 5-arylidenerhodanines 2.5 with malononitrile or by heterocyclization of compound 2.3 with benzylidenemalononitrile. Pyrazole\u2013thiazolidinone 2.3 in the presence of hydrazine hydrate undergoes ring transfomation with obtaining of the pyrazole-triazole 2.7 (Fig. 12\n).",
            "cite_spans": [
                {
                    "start": 205,
                    "end": 208,
                    "mention": "[5]",
                    "ref_id": "BIBREF50"
                },
                {
                    "start": 523,
                    "end": 527,
                    "mention": "[66]",
                    "ref_id": "BIBREF68"
                }
            ],
            "section": "The main methods for synthesis of 4-thiazolidinones with pyrazole/pyrazoline moiety in position 3",
            "ref_spans": [
                {
                    "start": 1274,
                    "end": 1281,
                    "mention": "Fig. 12",
                    "ref_id": "FIGREF3"
                }
            ]
        },
        {
            "text": "Various 4-thiazolidinones were synthesized by reaction of \u03b1-mercaptocarboxylic acids (especially thioglycolic acid) with isothiocyanates (R\u2013N\n000000000000\n000000000000\n000000000000\n111111111111\n000000000000\n111111111111\n000000000000\n000000000000\n000000000000\nCS). Thus, a pyrazole\u2013thiazolidinone 2.8 with phenyl sulfonamide linker group was obtained based on the mentioned approach [67]. There were described the synthesis of 3-pyrazole-substituted or polyheterocyclic derivatives of 4-thiazolidinones 2.9, 2.10 based on the reaction between thioglycolic acid and corresponding imines and methylidene-hydrazydes or three-component reaction involving thioglycolic acid, aromatic aldehydes and heterocyclic amines containing diazole fragment [68], [69], [70], [71], [72]. The reaction of isatin with heterocyclic amines led to Schiff's bases which were further reacted with thioglycolic acid to form 3-diazole-substituted indoline-spiro-thiazolidinones 2.11\n[73], [74] (Fig. 13\n).",
            "cite_spans": [
                {
                    "start": 382,
                    "end": 386,
                    "mention": "[67]",
                    "ref_id": "BIBREF69"
                },
                {
                    "start": 740,
                    "end": 744,
                    "mention": "[68]",
                    "ref_id": "BIBREF70"
                },
                {
                    "start": 746,
                    "end": 750,
                    "mention": "[69]",
                    "ref_id": "BIBREF71"
                },
                {
                    "start": 752,
                    "end": 756,
                    "mention": "[70]",
                    "ref_id": "BIBREF73"
                },
                {
                    "start": 758,
                    "end": 762,
                    "mention": "[71]",
                    "ref_id": "BIBREF74"
                },
                {
                    "start": 764,
                    "end": 768,
                    "mention": "[72]",
                    "ref_id": "BIBREF75"
                },
                {
                    "start": 956,
                    "end": 960,
                    "mention": "[73]",
                    "ref_id": "BIBREF76"
                },
                {
                    "start": 962,
                    "end": 966,
                    "mention": "[74]",
                    "ref_id": "BIBREF77"
                }
            ],
            "section": "The main methods for synthesis of 4-thiazolidinones with pyrazole/pyrazoline moiety in position 3",
            "ref_spans": [
                {
                    "start": 968,
                    "end": 975,
                    "mention": "Fig. 13",
                    "ref_id": "FIGREF4"
                }
            ]
        },
        {
            "text": "The reaction between trithiocarbonyl diglycolic acid and amines in alcohol or alcohol\u2013water medium (Holmberg synthesis) is a convenient and effective method for synthesis of 3-substituted rhodanines, especially based on the aromatic amines and carboxylic acid hydrazides [5]. The mentioned reaction was used by Augustin M. et al. for synthesis of rhodanine 2.12 with benzopyrazole fragment in position 3 [75] (Fig. 14\n).",
            "cite_spans": [
                {
                    "start": 271,
                    "end": 274,
                    "mention": "[5]",
                    "ref_id": "BIBREF50"
                },
                {
                    "start": 404,
                    "end": 408,
                    "mention": "[75]",
                    "ref_id": "BIBREF78"
                }
            ],
            "section": "The main methods for synthesis of 4-thiazolidinones with pyrazole/pyrazoline moiety in position 3",
            "ref_spans": [
                {
                    "start": 410,
                    "end": 417,
                    "mention": "Fig. 14",
                    "ref_id": "FIGREF5"
                }
            ]
        },
        {
            "text": "The method for synthesis of pyrazole\u2013thiazolidinone 2.15 (Fig. 15\n) with acetamide linker group was proposed based on the reaction of 5-arylidenerhodanine-3-acetic acid 2.13 and 5-aminopyrazole 2.14 in DMF in the presence of HATU (1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate) [76].",
            "cite_spans": [
                {
                    "start": 326,
                    "end": 330,
                    "mention": "[76]",
                    "ref_id": "BIBREF79"
                }
            ],
            "section": "The main methods for synthesis of 4-thiazolidinones with pyrazole/pyrazoline moiety in position 3",
            "ref_spans": [
                {
                    "start": 58,
                    "end": 65,
                    "mention": "Fig. 15",
                    "ref_id": "FIGREF6"
                }
            ]
        },
        {
            "text": "Synthesis of structurally related azolidine\u2013pyrazolines 2.16, 2.17 was proposed based on N-alkylation reaction of potassium salts of 2,4-thiazolidinedione, hydantoin and their 5-arylidene derivatives, obtained in situ (Fig. 16\n). 2-Chloro-1-(3,5-diarylpyrazolin-1-yl)-ethanones were successfully used as alkylating agents [77].",
            "cite_spans": [
                {
                    "start": 322,
                    "end": 326,
                    "mention": "[77]",
                    "ref_id": "BIBREF80"
                }
            ],
            "section": "The main methods for synthesis of 4-thiazolidinones with pyrazole/pyrazoline moiety in position 3",
            "ref_spans": [
                {
                    "start": 219,
                    "end": 226,
                    "mention": "Fig. 16",
                    "ref_id": "FIGREF7"
                }
            ]
        },
        {
            "text": "One of the main approaches for the synthesis of 5-pyrazole/pyrazoline substituted 4-thiazolidinones is based on Knoevenagel reaction of 4-thiazolidinones [5]. A numerous 1-, 3- and 5-substituted pyrazole-4-carbaldehydes were used as carbonyl compounds and allowed to obtain a series of new 2,4-thiazolidinediones [78], [79], [80], [81], rhodanines [82], [83], [84], [85], [86] and 2-imino-4-thiazolidinones with pyrazole moiety (compounds 3.1) [87], [88], [89]. The synthesis of pyrazolone\u2013thiazolidinones 3.2 was conducted by reaction of 3-arylrhodanines with 4-acetyl-5-methyl-2-phenyl-2,4-dihydropyrazol-3-one [90]. Position 5 of thiazolidine cycle was successfully modified in diazo coupling reaction [91] using pyrazolyl diazonium chloride yielding compound 3.3 (Fig. 17\n).",
            "cite_spans": [
                {
                    "start": 154,
                    "end": 157,
                    "mention": "[5]",
                    "ref_id": "BIBREF50"
                },
                {
                    "start": 313,
                    "end": 317,
                    "mention": "[78]",
                    "ref_id": "BIBREF81"
                },
                {
                    "start": 319,
                    "end": 323,
                    "mention": "[79]",
                    "ref_id": "BIBREF82"
                },
                {
                    "start": 325,
                    "end": 329,
                    "mention": "[80]",
                    "ref_id": "BIBREF84"
                },
                {
                    "start": 331,
                    "end": 335,
                    "mention": "[81]",
                    "ref_id": "BIBREF85"
                },
                {
                    "start": 348,
                    "end": 352,
                    "mention": "[82]",
                    "ref_id": "BIBREF86"
                },
                {
                    "start": 354,
                    "end": 358,
                    "mention": "[83]",
                    "ref_id": "BIBREF87"
                },
                {
                    "start": 360,
                    "end": 364,
                    "mention": "[84]",
                    "ref_id": "BIBREF88"
                },
                {
                    "start": 366,
                    "end": 370,
                    "mention": "[85]",
                    "ref_id": "BIBREF89"
                },
                {
                    "start": 372,
                    "end": 376,
                    "mention": "[86]",
                    "ref_id": "BIBREF90"
                },
                {
                    "start": 444,
                    "end": 448,
                    "mention": "[87]",
                    "ref_id": "BIBREF91"
                },
                {
                    "start": 450,
                    "end": 454,
                    "mention": "[88]",
                    "ref_id": "BIBREF92"
                },
                {
                    "start": 456,
                    "end": 460,
                    "mention": "[89]",
                    "ref_id": "BIBREF93"
                },
                {
                    "start": 613,
                    "end": 617,
                    "mention": "[90]",
                    "ref_id": "BIBREF95"
                },
                {
                    "start": 705,
                    "end": 709,
                    "mention": "[91]",
                    "ref_id": "BIBREF96"
                }
            ],
            "section": "The main approaches to the synthesis of 4-thiazolidinones with pyrazole/pyrazoline moiety in position 5",
            "ref_spans": [
                {
                    "start": 768,
                    "end": 775,
                    "mention": "Fig. 17",
                    "ref_id": "FIGREF8"
                }
            ]
        },
        {
            "text": "The synthesis of pyrazoline\u2013indoline\u2013thiazolidinone conjugates 3.5, 3.6 was realized by the Knoevenagel reaction of pyrazoline\u2013isatines 3.4 with 2,4-thiazolidinedione, 2-thioxo-4-thiazolidinone and 2-amino-4-thiazolidinone in the acetic acid medium and in the presence of sodium acetate [92] (Fig. 18\n).",
            "cite_spans": [
                {
                    "start": 287,
                    "end": 291,
                    "mention": "[92]",
                    "ref_id": "BIBREF97"
                }
            ],
            "section": "The main approaches to the synthesis of 4-thiazolidinones with pyrazole/pyrazoline moiety in position 5",
            "ref_spans": [
                {
                    "start": 293,
                    "end": 300,
                    "mention": "Fig. 18",
                    "ref_id": "FIGREF9"
                }
            ]
        },
        {
            "text": "The synthesis of pyrazolone\u2013thiazolidinones 3.7 (Fig. 19\n) was achieved based on the reaction between isonitrosorhodanines and 5-methyl-2,4-dihydropyrazol-3-one using piperidine as basic catalyst [93].",
            "cite_spans": [
                {
                    "start": 196,
                    "end": 200,
                    "mention": "[93]",
                    "ref_id": "BIBREF98"
                }
            ],
            "section": "The main approaches to the synthesis of 4-thiazolidinones with pyrazole/pyrazoline moiety in position 5",
            "ref_spans": [
                {
                    "start": 49,
                    "end": 56,
                    "mention": "Fig. 19",
                    "ref_id": "FIGREF10"
                }
            ]
        },
        {
            "text": "Magdy Ahmed Ibrahim et al. investigated a modification of 5-[4-oxo-4H-chromen-3-yl)methylene]-1,3-thiazolidin-2,4-dione 3.8, in particular in the ring-transformation reactions of chromene cycle with hydrazine hydrate and phenylhydrazine. These reactions allowed to obtain the corresponding pyrazole-thiazolidinones 3.9\n[94]. Using hydrazine hydrate the structure of final compounds depended on the reaction medium. Thus, 1N-non-substituted pyrazoles were obtained in alcohol medium and in the presence of sodium ethylate, while 1N-acetylderivatives were formed in acetic acid. The reaction of the compound 3.8 and 1-phenylpyrazolidin-3,5-dione in the presence of sodium ethylate led to formation of polyheterocyclic system 3.10 (Fig. 20\n).",
            "cite_spans": [
                {
                    "start": 319,
                    "end": 323,
                    "mention": "[94]",
                    "ref_id": "BIBREF99"
                }
            ],
            "section": "The main approaches to the synthesis of 4-thiazolidinones with pyrazole/pyrazoline moiety in position 5",
            "ref_spans": [
                {
                    "start": 729,
                    "end": 736,
                    "mention": "Fig. 20",
                    "ref_id": "FIGREF12"
                }
            ]
        },
        {
            "text": "Synthesis of 5-pyrazolyl-4-thiazolidinones with ethylene linker group 3.11 was performed via the [2+3]-cyclocondensation reaction of thiourea with \u03b3-pyrazolyl-\u03b1-chlorobutanoates [95] (see Fig. 21\n).",
            "cite_spans": [
                {
                    "start": 178,
                    "end": 182,
                    "mention": "[95]",
                    "ref_id": "BIBREF100"
                }
            ],
            "section": "The main approaches to the synthesis of 4-thiazolidinones with pyrazole/pyrazoline moiety in position 5",
            "ref_spans": [
                {
                    "start": 188,
                    "end": 195,
                    "mention": "Fig. 21",
                    "ref_id": "FIGREF13"
                }
            ]
        },
        {
            "text": "Pharmacologically attractive 5-(5-oxo-4,5-dihydro-1H-pyrazol-4-yl)rhodanines 3.12 (Fig. 22\n) were synthesized following heterocyclization of 2-thiazolidinyl-3-oxobutanoates with phenylhydrazine or conjugation of 4-bromopyrazolon-5-ones to 3-arylrhodanines [96].",
            "cite_spans": [
                {
                    "start": 256,
                    "end": 260,
                    "mention": "[96]",
                    "ref_id": "BIBREF101"
                }
            ],
            "section": "The main approaches to the synthesis of 4-thiazolidinones with pyrazole/pyrazoline moiety in position 5",
            "ref_spans": [
                {
                    "start": 83,
                    "end": 90,
                    "mention": "Fig. 22",
                    "ref_id": "FIGREF14"
                }
            ]
        },
        {
            "text": "The group of pyrazoline\u2013thiazolidinones 3.13 was obtained by reaction of 5-bromo-2,4-thiazolidindione with 3,5-diarylpyrazolines in alcohol medium (Fig. 23\n). The synthesized compounds were modified in position 3 of thiazolidine cycle by Mannich reaction with secondary cyclic amines and alkylation reactions forming 3.14, 3.15\n[97].",
            "cite_spans": [
                {
                    "start": 328,
                    "end": 332,
                    "mention": "[97]",
                    "ref_id": "BIBREF102"
                }
            ],
            "section": "The main approaches to the synthesis of 4-thiazolidinones with pyrazole/pyrazoline moiety in position 5",
            "ref_spans": [
                {
                    "start": 148,
                    "end": 155,
                    "mention": "Fig. 23",
                    "ref_id": "FIGREF15"
                }
            ]
        },
        {
            "text": "The following approach to the synthesis of pyrazoline\u2013thiazolidinone conjugates 3.16 with carbonyl methylidene linker group was based on the acylation reaction of 3,5-diarylpyrazolines (Fig. 24\n). The further reaction of substances 3.16 with chloroacetamides via N-alkylation reaction led to derivatives 3.17\n[97].",
            "cite_spans": [
                {
                    "start": 309,
                    "end": 313,
                    "mention": "[97]",
                    "ref_id": "BIBREF102"
                }
            ],
            "section": "The main approaches to the synthesis of 4-thiazolidinones with pyrazole/pyrazoline moiety in position 5",
            "ref_spans": [
                {
                    "start": 186,
                    "end": 193,
                    "mention": "Fig. 24",
                    "ref_id": "FIGREF16"
                }
            ]
        },
        {
            "text": "To explore the structure-antitrypanosomal activity relationship the pyrazoline\u2013thiazolidinone conjugates 3.18 were synthesized through the reaction of the 5-ethoxymethylidenerhodanines with 3,5-diarylpyrazolines (Fig. 25\n). 5-Pyrazoline substituted 4-thioxo-2-thiazolidinones 3.19 were obtained under the same conditions [98].",
            "cite_spans": [
                {
                    "start": 321,
                    "end": 325,
                    "mention": "[98]",
                    "ref_id": "BIBREF103"
                }
            ],
            "section": "The main approaches to the synthesis of 4-thiazolidinones with pyrazole/pyrazoline moiety in position 5",
            "ref_spans": [
                {
                    "start": 213,
                    "end": 220,
                    "mention": "Fig. 25",
                    "ref_id": "FIGREF17"
                }
            ]
        },
        {
            "text": "To continue the above mentioned study, 5-pyrazoline derivatives of 4-thiazolidinone 3.21 with oxoethylamino-methylene linker group were synthesized by modification of rhodanine-5-carboxylic acid 3.20 in the reaction with pyrazolines and in the presence of DCC (dicyclohexylcarbodiimide) [98] (Fig. 26\n).",
            "cite_spans": [
                {
                    "start": 287,
                    "end": 291,
                    "mention": "[98]",
                    "ref_id": "BIBREF103"
                }
            ],
            "section": "The main approaches to the synthesis of 4-thiazolidinones with pyrazole/pyrazoline moiety in position 5",
            "ref_spans": [
                {
                    "start": 293,
                    "end": 300,
                    "mention": "Fig. 26",
                    "ref_id": "FIGREF18"
                }
            ]
        },
        {
            "text": "Antitumor activity evaluation is promising for the thiazolidinones with pyrazoline fragment. The in vitro anticancer activity of thiazolidinones with pyrazoline cycle in position 2 (4.2) or 4 (4.3) of thiazolidine was tested by the National Cancer Institute (NCI) and most of them displayed anticancer activity on leukemia, melanoma, lung, colon, CNS, ovarian, renal, prostate and breast cancers cell lines. The most efficient anticancer compound 4.1 was found to be active with selective influence on colon cancer cell lines, especially on HT 29 (lgGI50 = \u22126.37) [33]. The SAR study revealed that: (1) anticancer activity of compounds is sensitive to the nature of substituent in position 5 of thiazolone cycle, (2) introduction of p-OH group in 5-benzylidene fragment enhanced potency, and (3) the positional isomers, namely 2-pyrazoline (4.2) and 4-pyrazoline (4.3) substituted thiazolones are promising compounds for further optimization (Fig. 27\n).",
            "cite_spans": [
                {
                    "start": 564,
                    "end": 568,
                    "mention": "[33]",
                    "ref_id": "BIBREF32"
                }
            ],
            "section": "Antitumor activity of pyrazole/pyrazoline-thiazolidinone hybrids ::: Biological activity of pyrazole-thiazoldinones derivatives and reated heterocyclic hybrids",
            "ref_spans": [
                {
                    "start": 943,
                    "end": 950,
                    "mention": "Fig. 27",
                    "ref_id": "FIGREF19"
                }
            ]
        },
        {
            "text": "Novel pyrazoline\u2013thiazolidinone\u2013isatin 4.4 and pyrazole-indoline-2-one 4.5 conjugates were designed as potential anticancer agents (Fig. 28\n). The most effective anticancer compound 4.6 was found to be active with a mean GI50 and TGI values of 0.071 \u03bcM and 0.76 \u03bcM, respectively and demonstrated the highest antiproliferative influence on the non-small cell lung cancer cell line HOP-92 (GI50 < 0.01 \u03bcM), colon cancer line HCT-116 (GI50 = 0.018 \u03bcM), CNS cancer cell line SNB-75 (GI50 = 0.0159 \u03bcM), ovarian cancer cell line NCI/ADR-RES (GI50 = 0.0169 \u03bcM) and renal cancer cell line RXF 393 (GI50 = 0.0197 \u03bcM). The SAR study revealed that: (1) potent anticancer activity of tested compounds depended on the presence of a combination of three heterocycles in one molecule, thus the pyrazoline\u2013thiazolidinone\u2013isatin conjugates were more active in comparison with pyrazoline\u2013thiazolidinone or pyrazole-indoline-2-one systems; (2) attachment of halogen (Br or Cl) to 5-position of isatin scaffold allowed to gain one log unit of activity (GI50 level), in comparison with 5-unsubstituted isatin analogs; (3) introduction of a methyl group or CH2COOH group at 1N-position of isatin fragment led to the loss of activity; (4) the nature of a substituent in the 5-aryl fragment also had an influence on the antitumor activity. Therefore, the introduction of electron-withdrawing group \u2013 4-chlorine improved the antiproliferative activity in comparison with electron-donor 2-OH, 4-OMe and 4-NMe2 groups. This would indicate that decreased of electron density on 5-aryl moiety is important for the inhibitory activity; and (5) substitution of the phenyl fragment in 3 position of pyrazoline cycle on naphthalene-2-yl substituent did not have significant influence on antitumor activity, but introduction of the 4-methoxyphenyl group in the mentioned position limited this effect [32].",
            "cite_spans": [
                {
                    "start": 1866,
                    "end": 1870,
                    "mention": "[32]",
                    "ref_id": "BIBREF31"
                }
            ],
            "section": "Antitumor activity of pyrazole/pyrazoline-thiazolidinone hybrids ::: Biological activity of pyrazole-thiazoldinones derivatives and reated heterocyclic hybrids",
            "ref_spans": [
                {
                    "start": 132,
                    "end": 139,
                    "mention": "Fig. 28",
                    "ref_id": "FIGREF20"
                }
            ]
        },
        {
            "text": "Y. Rajendra Prasad et al. synthesized a series of pyrazoline\u2013thiazoles 4.7, 4.8, and examined their antitumor activity in vitro on tumor lines: Hela (human cervix carcinoma cell line), A549 (human lung adenocarcinoma cell line), MCF-7 (human breast adenocarcinoma cell line), A2780 (human ovarian cancer cell line) and BGC-823 (human gastric cancer cell line), using the MTT method. As a result of studies two hit-compounds 4.10 and 4.11 were selected. SAR analysis showed that the determining factor for expression of antitumor activity is the structure of the substituent in the 4 position of thiazole (Fig. 29\n). A modification of the ester group into hydrazide and, subsequently, a hydrazone gave the potentiation of antitumor properties. At the same time, pyrazoline\u2013thiazolidinones 4.9 had no significant cytotoxicity [35].",
            "cite_spans": [
                {
                    "start": 824,
                    "end": 828,
                    "mention": "[35]",
                    "ref_id": "BIBREF34"
                }
            ],
            "section": "Antitumor activity of pyrazole/pyrazoline-thiazolidinone hybrids ::: Biological activity of pyrazole-thiazoldinones derivatives and reated heterocyclic hybrids",
            "ref_spans": [
                {
                    "start": 605,
                    "end": 612,
                    "mention": "Fig. 29",
                    "ref_id": "FIGREF21"
                }
            ]
        },
        {
            "text": "The series of pyrazoline\u2013thiazolidine-based compounds were tested for antitumor activity according to standard NCI protocol and 4-thiazolidinone derivatives with pyrazoline fragment 4.12, 4.14, 4.17 showed moderate cytostatic effect. The group of publications includes the synthesis of these pyrazoline\u2013thiazolidinones 4.12, 4.14, 4.17 and pyrazoline\u2013thiazolidines 4.13, 4.15, 4.16, 4.18 with diversity of substitution in pyrazole core. The analysis of mentioned results demonstrates that the modification of pyrazoline fragment is not crucial to the implementation of antineoplastic action (Fig. 30\n). This statement is evidenced by the level of efficiency of compounds 4.12\u20134.18 with moderate rates of effective concentration [48], [49], [50], [51].",
            "cite_spans": [
                {
                    "start": 728,
                    "end": 732,
                    "mention": "[48]",
                    "ref_id": "BIBREF48"
                },
                {
                    "start": 734,
                    "end": 738,
                    "mention": "[49]",
                    "ref_id": "BIBREF49"
                },
                {
                    "start": 740,
                    "end": 744,
                    "mention": "[50]",
                    "ref_id": "BIBREF51"
                },
                {
                    "start": 746,
                    "end": 750,
                    "mention": "[51]",
                    "ref_id": "BIBREF52"
                }
            ],
            "section": "Antitumor activity of pyrazole/pyrazoline-thiazolidinone hybrids ::: Biological activity of pyrazole-thiazoldinones derivatives and reated heterocyclic hybrids",
            "ref_spans": [
                {
                    "start": 592,
                    "end": 599,
                    "mention": "Fig. 30",
                    "ref_id": "FIGREF23"
                }
            ]
        },
        {
            "text": "Magdy I. El-Zahar et al. [55] synthesized a group of benzofuran\u2013pyrazoles with various heterocycles, including thiazole (4.19) and thiazolidine (4.20) fragments for screening of antitumor activity on lines: HEPG2 (liver carcinoma cell line) and HELA (cervix carcinoma cell line). Interestingly, each of these compounds showed selective effect on one of the lines similar to 5-fluorouracil (Fig. 31\n).",
            "cite_spans": [
                {
                    "start": 25,
                    "end": 29,
                    "mention": "[55]",
                    "ref_id": "BIBREF56"
                }
            ],
            "section": "Antitumor activity of pyrazole/pyrazoline-thiazolidinone hybrids ::: Biological activity of pyrazole-thiazoldinones derivatives and reated heterocyclic hybrids",
            "ref_spans": [
                {
                    "start": 390,
                    "end": 397,
                    "mention": "Fig. 31",
                    "ref_id": "FIGREF24"
                }
            ]
        },
        {
            "text": "Synthesis and study of antitumor activity of pyrazole-thiazolidinone\u2013triazoles on lung cancer MCF-7 line were conducted by Arun M. Isloor et al. [40]. Among the studied conjugates the compound 4.21 was the most active with the effective concentration IC50 = 22 \u03bcg/mL. The presence of o-tolyl fragment was most favorable for the anticancer effect, while substitution with naphthyl ring caused complete loss of activity (Fig. 32\n).",
            "cite_spans": [
                {
                    "start": 145,
                    "end": 149,
                    "mention": "[40]",
                    "ref_id": "BIBREF40"
                }
            ],
            "section": "Antitumor activity of pyrazole/pyrazoline-thiazolidinone hybrids ::: Biological activity of pyrazole-thiazoldinones derivatives and reated heterocyclic hybrids",
            "ref_spans": [
                {
                    "start": 419,
                    "end": 426,
                    "mention": "Fig. 32",
                    "ref_id": "FIGREF25"
                }
            ]
        },
        {
            "text": "An important achievement in the study of anticancer pyrazole-thiazolidinone hybrid compounds is the establishing of the necroptosis inhibition for pseudothiohydantoin derivatives with pyrazole moiety in 5 position (Fig. 33\n). Among these derivatives a potential inhibitor Necrostatin-7 (Nec-7) was identified with the activity index of 10.6 \u03bcM. Further studies aiming to optimize of Nec-7 molecule, were focused on the modification of thiazole fragment, replacement of substituents in the phenyl ring and replacement of pyrazole cycle by other heterocycles. It was established that the replacement of thiazole fragment by the 1,3,4-thiadiazole led to the complete loss of activity. The introduction of the methyl group in the 4 position of thiazole caused a slight gain of inhibitory action, while presence of methyl in the 5 position of thiazole had a negative effect. The most effective direction for modification of Nec-7 was the replacement of fluorine atom in the 4 position of benzene core. Thus, the introduction of morpholine (4.22), phenol (4.23) and phenyl sulphanilic (4.24) fragments allowed to get 3\u20137 fold potentiation in comparison to Nec-7. In general, it should be noted that the presence of the substituent in the 4 position and its nature was crucial for the implementation of necroptosis inhibitory activity, because the change of a fluorine atom position was accompanied by loss of activity. The authors synthesized a group of related compounds with aromatic heterocycles (triazole and isooxazole) to establish the impact of pyrazole cycle for activity. This modification resulted in the loss of inhibitory activity, which confirmed the importance of pyrazole moiety in the analogs Nec-7 [87].",
            "cite_spans": [
                {
                    "start": 1709,
                    "end": 1713,
                    "mention": "[87]",
                    "ref_id": "BIBREF91"
                }
            ],
            "section": "Antitumor activity of pyrazole/pyrazoline-thiazolidinone hybrids ::: Biological activity of pyrazole-thiazoldinones derivatives and reated heterocyclic hybrids",
            "ref_spans": [
                {
                    "start": 215,
                    "end": 222,
                    "mention": "Fig. 33",
                    "ref_id": "FIGREF26"
                }
            ]
        },
        {
            "text": "The study of antitumor activity for pyrazole-rhodanines allowed to identify the compound 4.25, which proved effective inhibitory effect on the most of the 60 tumor lines at micromolar concentrations according to NCI protocol (Fig. 34\n). The substance 4.25 was characterized by a selective effect on leukemia and lung cancer cell lines \u2013 especially on HOP-92 (lung cancer) with the values of effective concentration and cytotoxicity GI50 = 0.62 \u03bcM and LC50 > 100 \u03bcM, respectively [82].",
            "cite_spans": [
                {
                    "start": 479,
                    "end": 483,
                    "mention": "[82]",
                    "ref_id": "BIBREF86"
                }
            ],
            "section": "Antitumor activity of pyrazole/pyrazoline-thiazolidinone hybrids ::: Biological activity of pyrazole-thiazoldinones derivatives and reated heterocyclic hybrids",
            "ref_spans": [
                {
                    "start": 226,
                    "end": 233,
                    "mention": "Fig. 34",
                    "ref_id": "FIGREF27"
                }
            ]
        },
        {
            "text": "Manal Sarkis et al. carried out the synthesis of new bis-thiazolone derivatives as potential inhibitors of CDC25V phosphatase (specified enzyme involved in cell cycle progression and unregulated tumor development). Aiming to investigate the selectivity, the affinity of the compounds was studied to PTP1B (Protein Tyrosine Phosphatase 1B) and VHR (Vaccinia virus H1 Related \u2013 a dual-specificity phosphatase). Overall 31 compounds from bis-thiazolidinone group were synthesized and most of them displayed inhibitory activity with micromolar IC50 values lower than the corresponding monomers. Mentioned group of the compounds included the thiazolidinone\u2013indazole conjugate 4.26 (Fig. 35\n). It was established that the replacement of a 4-hydroxyphenyl fragment with indazole was accompanied by selective inhibition of CDC25B phosphatase and loss of PTP1B inhibitory activity (abolished PTP1B inhibition) [99].",
            "cite_spans": [
                {
                    "start": 901,
                    "end": 905,
                    "mention": "[99]",
                    "ref_id": "BIBREF104"
                }
            ],
            "section": "Antitumor activity of pyrazole/pyrazoline-thiazolidinone hybrids ::: Biological activity of pyrazole-thiazoldinones derivatives and reated heterocyclic hybrids",
            "ref_spans": [
                {
                    "start": 677,
                    "end": 684,
                    "mention": "Fig. 35",
                    "ref_id": "FIGREF28"
                }
            ]
        },
        {
            "text": "Screening of in vitro antitumor activity for 5-pyrazoline substituted 4-thiazolidinones (compounds 4.27 and 4.28) was carried out within the DTP NCI [77], [97]. Overall tested substances had a moderate activity, but two compounds were identified with selective effect on leukemia cell lines with effective concentration GI50 2.12\u20134.58 \u03bcM (4.29) and 1.64\u20133.20 \u03bcM (4.30). SAR analysis showed that the introduction of the linker group between heterocycles promoted the potentiation of antitumor activity, however, modification of 3N-position of thiazolidinone cycle via Mannich reaction and alkylation was not effective approach to optimization of hit-compounds (Fig. 36\n).",
            "cite_spans": [
                {
                    "start": 149,
                    "end": 153,
                    "mention": "[77]",
                    "ref_id": "BIBREF80"
                },
                {
                    "start": 155,
                    "end": 159,
                    "mention": "[97]",
                    "ref_id": "BIBREF102"
                }
            ],
            "section": "Antitumor activity of pyrazole/pyrazoline-thiazolidinone hybrids ::: Biological activity of pyrazole-thiazoldinones derivatives and reated heterocyclic hybrids",
            "ref_spans": [
                {
                    "start": 660,
                    "end": 667,
                    "mention": "Fig. 36",
                    "ref_id": "FIGREF29"
                }
            ]
        },
        {
            "text": "The search for new antimicrobial and antifungal agents among pyrazoline\u2013thiazolidinone related conjugates is a promising direction for biological testing of mentioned compounds. Mervat M. El-Enany et al. synthesized the group of 4-thiazolidinones and thiazoles with pyrazoline fragment in 2 position and studied their antimicrobial activity against Gram-positive (Staphylococcus aureus, Bacillus subtilis), gram-negative bacteria (Escherichia coli, Pseudomonas aeruginosa) and fungi Candida albicans\n[24]. However, the compound 4.31 was inactive to any of the microorganisms, while activity of 4.32 on B. subtilis appeared commensurate with Amoxacillin and Propenicillin (Fig. 37\n). The research of Bakr F. Abdel-Wahab et al. was more successful. The authors synthesized a group of triazole\u2013pyrazoline\u2013thiazoles and corresponding 4-thiazolidinones and studied their activity against gram-positive bacteria (S. aureus ATCC 29213, B. subtilis ATCC6633, Bacillus megaterium ATCC 9885, Sarcina lutea), gram-negative bacteria (Klebseilla pneumonia ATCC13883, P. aeruginosa ATCC27953, E. coli ATCC 25922) and fungi (Saccharomyces cerevisiae and C. albicans NRRL Y-477) compared with Ciprofloxacin and Ketoconazole [23]. Among the tested thiazole\u2013pyrazolines compound 4.33 showed the highest activity for strain P. aeruginosa (MIC = 8.25 \u03bcg/mL), which was twice higher than for Ciprofloxacin. Activity of 4.34 appeared commensurate with the drug for bacteria S. aureus and B. subtilis (MIC = 8.25 \u03bcg/mL). At the same time 4.35 showed a high antifungal activity (MIC = 8.25 \u03bcg/mL). It should be noted that the replacement of thiazole fragment with the 4-thiazolidinone was accompanied by the loss of antimicrobial activity against most types of bacteria and fungi, but compound 4.36 showed the highest activity in B. megaterium and E. coli, which were much less sensitive to the action of thiazole\u2013pyrazolines (Fig. 37). Study of antimicrobial activity for structurally related quinoline\u2013pyrazoline\u2013thiazolidones 4.37 against strains E. coli (MTCC 443), P. aeruginosa (MTCC 1688), S. aureus (MTCC 96), Streptococcus pyogenes (MTCC 442) and antifungal effect on C. albicans (MTCC 227), Aspergillus niger (MTCC 282) and Aspergillus clavatus (MTCC 1323) evidenced of their minor or moderate activity on most types of microorganisms with MIC values range = 50\u2013500 \u03bcg/mL [25]. However, among the above groups of compounds 4.38 could be selected, which showed 2\u20138 times higher bactericidal activity in experiment than Ampicillin and was twice active than Griseofulvin on fungi. The mentioned compound showed the highest activity with the value of MIC 12.5 \u03bcg/mL to P. aeruginosa (Fig. 37).",
            "cite_spans": [
                {
                    "start": 500,
                    "end": 504,
                    "mention": "[24]",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 1208,
                    "end": 1212,
                    "mention": "[23]",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 2358,
                    "end": 2362,
                    "mention": "[25]",
                    "ref_id": "BIBREF23"
                }
            ],
            "section": "Antimicrobial and antifungal activity of pyrazoline\u2013thiazolidinones ::: Biological activity of pyrazole-thiazoldinones derivatives and reated heterocyclic hybrids",
            "ref_spans": [
                {
                    "start": 672,
                    "end": 679,
                    "mention": "Fig. 37",
                    "ref_id": "FIGREF30"
                },
                {
                    "start": 1903,
                    "end": 1910,
                    "mention": "Fig. 37",
                    "ref_id": "FIGREF30"
                },
                {
                    "start": 2666,
                    "end": 2673,
                    "mention": "Fig. 37",
                    "ref_id": "FIGREF30"
                }
            ]
        },
        {
            "text": "C.S. Reddy et al. performed the synthesis and study of antimicrobial activity of thiazolidinone\u2013pyrazoles 4.39 against the B. subtilis, S. aureus, E. coli and S. pyogenes. It was established the moderate effect of mentioned compounds (MIC = 6.25\u201350 \u03bcg/mL) (Fig. 38\n). The introduction of chlorine, nitro or hydroxyl groups in the para-position of the benzene ring resulted in 2\u20134 fold potentiation of activity in comparison to 3-phenyl-4-thiazolidinones. However, replacement of the phenyl moiety to pyridine (4.40) or pyrimidine was particularly effective, which allowed to get 4\u20138 fold enhance of efficiency [100].",
            "cite_spans": [
                {
                    "start": 610,
                    "end": 615,
                    "mention": "[100]",
                    "ref_id": "BIBREF2"
                }
            ],
            "section": "Antimicrobial and antifungal activity of pyrazoline\u2013thiazolidinones ::: Biological activity of pyrazole-thiazoldinones derivatives and reated heterocyclic hybrids",
            "ref_spans": [
                {
                    "start": 257,
                    "end": 264,
                    "mention": "Fig. 38",
                    "ref_id": "FIGREF31"
                }
            ]
        },
        {
            "text": "The pyrazole\u2013thiazolidinones 4.41 or pyrazole\u2013thiazoles 4.42, coupled by hydrazone linker group were investigated as promising agents with antimicrobial and antifungal activity. It was found that the compound 4.41b (R = Me) showed comparable activity (MIC = 25 \u03bcg/mL) with Ampicillin against E. coli, and the compound 4.41c (R = Cl) appeared to be the most active on C. albicans (MIC = 12.5 \u03bcg/mL) (Fig. 39\n). Overall, pyrazole-thiazolidinones 4.41 had higher activity than related pyrazole-thiazoles 4.42\n[60]. Adnan A. Bekhit et al. synthesized the pyrazoline\u2013thiazoles and thiazolidinones with sulfanilamide group. Among the studied pyrazole-thiazolidinones 4.43 and pyrazole\u2013thiazoles 4.44 the compounds 4.43b (R = Me) and 4.44a (R = H) (Fig. 39) were most effective against E. coli (MIC = 25 \u03bcg/mL) [56].",
            "cite_spans": [
                {
                    "start": 506,
                    "end": 510,
                    "mention": "[60]",
                    "ref_id": "BIBREF62"
                },
                {
                    "start": 804,
                    "end": 808,
                    "mention": "[56]",
                    "ref_id": "BIBREF57"
                }
            ],
            "section": "Antimicrobial and antifungal activity of pyrazoline\u2013thiazolidinones ::: Biological activity of pyrazole-thiazoldinones derivatives and reated heterocyclic hybrids",
            "ref_spans": [
                {
                    "start": 399,
                    "end": 406,
                    "mention": "Fig. 39",
                    "ref_id": "FIGREF32"
                },
                {
                    "start": 742,
                    "end": 749,
                    "mention": "Fig. 39",
                    "ref_id": "FIGREF32"
                }
            ]
        },
        {
            "text": "The study of wide range of antimicrobial and antifungal activities of new benzofuranyl\u2013pyrazoles with thiazolidinone fragment was conducted by Bakr F. Abdel-Wahab et al. The compound 4.45 showed activity against C. albicans and B. subitilis, and thiazole-derivative 4.46 was effective against the E. coli\n[62] (Fig. 40\n). To continue the research of pyrazole derivatives with different heterocycles, authors conducted the synthesis of new derivatives of pyrazole with thiophene fragment 4.47\u20134.49, including pyrazole-thiazolidine 4.50 (Fig. 40) and offered a wide range of biological studies, including the evaluation of antimicrobial activity against the following microorganisms: S. aureus ATCC 29213, B. subtilis ATCC6633, Salmonella typhi, Enterobacter Cloaca ATCC3047, K. peneumoniae ATCC13883, P. aeroginosa ATCC27953, E. coli ATCC 25922, Enterococcus faecalis ATCC29212, Mycobacterium phlei, S. cervesiae and C. albicans NRRL Y-477. Among the tested compounds 4.47 and 4.49 showed hihg/good or moderate efficiency against all strains of microorganisms. While compound 4.48 had proved to be the most effective on E. faecalis (MIC = 83.3 \u03bcg/mL), compound 4.50 was effective bactericidal agent on the strain S. aureus (MIC = 20.8 \u03bcg/mL) and showed significant antifungal effect on S. cervesia (MIC = 41.6 \u03bcg/mL) [58].",
            "cite_spans": [
                {
                    "start": 305,
                    "end": 309,
                    "mention": "[62]",
                    "ref_id": "BIBREF64"
                },
                {
                    "start": 1316,
                    "end": 1320,
                    "mention": "[58]",
                    "ref_id": "BIBREF59"
                }
            ],
            "section": "Antimicrobial and antifungal activity of pyrazoline\u2013thiazolidinones ::: Biological activity of pyrazole-thiazoldinones derivatives and reated heterocyclic hybrids",
            "ref_spans": [
                {
                    "start": 311,
                    "end": 318,
                    "mention": "Fig. 40",
                    "ref_id": "FIGREF34"
                },
                {
                    "start": 536,
                    "end": 543,
                    "mention": "Fig. 40",
                    "ref_id": "FIGREF34"
                }
            ]
        },
        {
            "text": "Evaluation of antimicrobial activity for thiazolidines with 5-pyrazolone fragment 4.51\u20134.53 (Fig. 41\n) revealed their effectiveness on B. subtilis NCTC 10400, S. aureus ATCC 25923, E. coli ATCC 25922, P. aeruginosa ATCC 10415) and fungi C. albicans TMRU 3669, A. niger ATCC 6265\n[57].",
            "cite_spans": [
                {
                    "start": 279,
                    "end": 283,
                    "mention": "[57]",
                    "ref_id": "BIBREF58"
                }
            ],
            "section": "Antimicrobial and antifungal activity of pyrazoline\u2013thiazolidinones ::: Biological activity of pyrazole-thiazoldinones derivatives and reated heterocyclic hybrids",
            "ref_spans": [
                {
                    "start": 93,
                    "end": 100,
                    "mention": "Fig. 41",
                    "ref_id": "FIGREF35"
                }
            ]
        },
        {
            "text": "An antimicrobial screening was carried out for 3-pyrazolinyl-4-thiazolidinones against gram-positive bacteria S. aureus MTCC096, B. subtilis MTCC 441 and Staphylococcus epidermis MTCC435, gram-negative bacteria E. coli MTCC 443, P. aeruginosa MTCC 424, S. typhi MTCC 733 and K. pneumoniae MTCC 432, and antifungal effect was studied on A. niger MTCC 282, Aspergillus fumigatus MTCC 343, Aspergillus flavus MTCC 277 and C. albicans MTCC 227. In general the tested compounds (Fig. 42\n) showed promising antimicrobial activity. However, it could be emphasized that the bis-spiroindolones 4.55 showed better growth inhibition compared with compounds 4.54\n[101].",
            "cite_spans": [
                {
                    "start": 651,
                    "end": 656,
                    "mention": "[101]",
                    "ref_id": "BIBREF3"
                }
            ],
            "section": "Antimicrobial and antifungal activity of pyrazoline\u2013thiazolidinones ::: Biological activity of pyrazole-thiazoldinones derivatives and reated heterocyclic hybrids",
            "ref_spans": [
                {
                    "start": 474,
                    "end": 481,
                    "mention": "Fig. 42",
                    "ref_id": "FIGREF36"
                }
            ]
        },
        {
            "text": "S.S. Reddy et al. proposed the synthesis of pyrazole-pyrimidine\u2013thiazolidinones 4.56 (Fig. 43\n) and the study of their antimicrobial (B. subtilis MTCC 441, Bacillus sphaericus MTCC 11, S. aureus MTCC 96, P. aeruginosa MTCC 741, Klobsinella aerogenes MTCC 39 and Chromobacterium violaceum MTCC 2625) and antifungal (C. albicans ATCC 10231, Aspergillus fumigatus HIC 6094, Trichophyton rubrum IFO 9185 and Trichophyton mentagrophytes IFO 40996) activities. Despite the wide range of antimicrobial research, none of the tested compounds was more active than Penicillin (MIC = 1.56\u201312.5 \u03bcg/mL). The range value of the minimum inhibitory concentration was 13\u201330 \u03bcg/mL. However, it should be noted an antifungal activity of pyrazole-pyrimidine\u2013thiazolidinones 4.56. The compounds with furane and 4-dimethylaminophenyl-groups in position 2 of thiazolidinone showed a higher or comparable efficacy (MIC = 14\u201322 \u03bcg/mL) to Fluconazole [72].",
            "cite_spans": [
                {
                    "start": 925,
                    "end": 929,
                    "mention": "[72]",
                    "ref_id": "BIBREF75"
                }
            ],
            "section": "Antimicrobial and antifungal activity of pyrazoline\u2013thiazolidinones ::: Biological activity of pyrazole-thiazoldinones derivatives and reated heterocyclic hybrids",
            "ref_spans": [
                {
                    "start": 86,
                    "end": 93,
                    "mention": "Fig. 43",
                    "ref_id": "FIGREF37"
                }
            ]
        },
        {
            "text": "Among 5-pyrazolyl-4-thiazolidinones the compounds 4.57 (Fig. 44\n) were investigated for their antimicrobial activity. The most effective pyrazole-thiazolidinones included the 4-Br-phenyl or thiophene fragments in molecules and showed 2\u20134 times higher efficiency (MIC = 16\u201331 \u03bcg/mL) in comparison with other derivatives [80]. The moderate antimicrobial activity towards E. coli and S. aureus was identified for 3N-glycoside substituted 2-thioxo-4-thiazolidinone derivatives 4.58 (Fig. 44). The p-bromophenyl substituted derivative showed the highest efficiency against E. coli (MIC = 143 \u03bcg/mL) but was 3 times less active than tetracycline (MIC = 39 \u03bcg/mL) [84].",
            "cite_spans": [
                {
                    "start": 319,
                    "end": 323,
                    "mention": "[80]",
                    "ref_id": "BIBREF84"
                },
                {
                    "start": 657,
                    "end": 661,
                    "mention": "[84]",
                    "ref_id": "BIBREF88"
                }
            ],
            "section": "Antimicrobial and antifungal activity of pyrazoline\u2013thiazolidinones ::: Biological activity of pyrazole-thiazoldinones derivatives and reated heterocyclic hybrids",
            "ref_spans": [
                {
                    "start": 56,
                    "end": 63,
                    "mention": "Fig. 44",
                    "ref_id": "FIGREF38"
                },
                {
                    "start": 479,
                    "end": 486,
                    "mention": "Fig. 44",
                    "ref_id": "FIGREF38"
                }
            ]
        },
        {
            "text": "However, the most promising group of antimicrobial agents is 5-pyrazolylrhodanines 4.59\u20134.63\n[85], [86], [102], [103]. Antimicrobial activity of these substances was studied against methicillin- (MRSA) and quinolone-resistant (QRSA) S. aureus. Compounds 4.59\u20134.61 exhibited stronger activity than the standard drugs, norfloxacin and oxacillin, with MIC values of 1\u20132 mg/mL. SAR analysis for pyrazole-rhodanine derivatives 4.62, 4.63 revealed the importance of aryl moiety presence in the pyrazole ring for expression of antimicrobial action and a number of substituents that considerably increased effectiveness were identified (Fig. 45\n).",
            "cite_spans": [
                {
                    "start": 93,
                    "end": 97,
                    "mention": "[85]",
                    "ref_id": "BIBREF89"
                },
                {
                    "start": 99,
                    "end": 103,
                    "mention": "[86]",
                    "ref_id": "BIBREF90"
                },
                {
                    "start": 105,
                    "end": 110,
                    "mention": "[102]",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 112,
                    "end": 117,
                    "mention": "[103]",
                    "ref_id": "BIBREF5"
                }
            ],
            "section": "Antimicrobial and antifungal activity of pyrazoline\u2013thiazolidinones ::: Biological activity of pyrazole-thiazoldinones derivatives and reated heterocyclic hybrids",
            "ref_spans": [
                {
                    "start": 629,
                    "end": 636,
                    "mention": "Fig. 45",
                    "ref_id": "FIGREF39"
                }
            ]
        },
        {
            "text": "The search for new chemotherapeutic agents among pyrazole\u2013thiazolidinones is not limited by anticancer and antimicrobial studies. The evaluation of antiviral and antiparasitic activities for mentioned hybrid compounds allowed identifying promising hit-compounds and conducting SAR analysis. Osama I. El-Sabbagh proposed the synthesis of a group of pyrazoline\u2013thiazolidinones 4.64 and structurally related pyrazoline\u2013thiazoles 4.65 (Fig. 46\n) and performed a study of a wide range of antiviral activity. It should be noted that described compounds showed selective activity. However, one derivative (Ar = 4-Me-C6H4) among compounds 4.64 had moderate efficacy against herpes simplex virus type 1, herpes simplex virus type 2, vaccinia virus, vesicular stomatitis virus and thymidine kinase-deficient herpes simplex virus type 1 with value of the effective concentration of 4 \u03bcg/mL and cytotoxicity value 20 \u03bcg/mL (SI = 5) [29].",
            "cite_spans": [
                {
                    "start": 920,
                    "end": 924,
                    "mention": "[29]",
                    "ref_id": "BIBREF27"
                }
            ],
            "section": "Antiviral and antiparasitic activity of pyrazole\u2013thiazolidinone hybrids ::: Biological activity of pyrazole-thiazoldinones derivatives and reated heterocyclic hybrids",
            "ref_spans": [
                {
                    "start": 432,
                    "end": 439,
                    "mention": "Fig. 46",
                    "ref_id": "FIGREF40"
                }
            ]
        },
        {
            "text": "Study of thiazolidinones with sulfonamide fragment against the hepatitis C virus, conducted by Yili Ding et al. allowed to identify a number of promising antiviral agents [104]. Among the studied 4-thiazolidinones the pyrazole derivative 4.66 (Fig. 46) showed moderate effectiveness (IC50 = 10 \u03bcg/mL and EC50 = 70 \u03bcg/mL and cytotoxicity index CC50 = 90 \u03bcg/mL).",
            "cite_spans": [
                {
                    "start": 171,
                    "end": 176,
                    "mention": "[104]",
                    "ref_id": "BIBREF6"
                }
            ],
            "section": "Antiviral and antiparasitic activity of pyrazole\u2013thiazolidinone hybrids ::: Biological activity of pyrazole-thiazoldinones derivatives and reated heterocyclic hybrids",
            "ref_spans": [
                {
                    "start": 244,
                    "end": 251,
                    "mention": "Fig. 46",
                    "ref_id": "FIGREF40"
                }
            ]
        },
        {
            "text": "5-Pyrazoline substituted 4-thiazolidinones (Fig. 47\n) were studied for their antiviral activity against SARS coronavirus (SARS CoV) and influenza types A and B viruses (Flu A, Flu B), as well as antitrypanosomal effect against Trypanosoma brucei brucei (Tbb) and Trypanosoma brucei gambiense (Tbg). Overall compounds were characterized by the similar values of anti-influenza viruses' activity and cytotoxicity with selectivity indexes 1.0 to 2.1. Compound 4.68 had moderate activity against duck strain of influenza A with 50% effective concentration (EC50) 21.78 \u03bcM and selectivity index (SI) > 16.3. In general, tested compounds had no antiviral activity against SARS CoV [97]. The screening was conducted for compounds (Fig. 45) against Trypanosoma brucei brucei (Tbb) and Trypanosoma brucei gambiense (Tbg). The results showed moderate antitrypanosomal activity of compounds 4.67, 4.69 and 4.70 against both strains of tested parasites (activity indexes IC50 (Tbb) = 5.43\u201313.87 \u03bcM and IC50 (Tbg) = 2.53\u20136.66 \u03bcM) [97].",
            "cite_spans": [
                {
                    "start": 675,
                    "end": 679,
                    "mention": "[97]",
                    "ref_id": "BIBREF102"
                },
                {
                    "start": 1017,
                    "end": 1021,
                    "mention": "[97]",
                    "ref_id": "BIBREF102"
                }
            ],
            "section": "Antiviral and antiparasitic activity of pyrazole\u2013thiazolidinone hybrids ::: Biological activity of pyrazole-thiazoldinones derivatives and reated heterocyclic hybrids",
            "ref_spans": [
                {
                    "start": 44,
                    "end": 51,
                    "mention": "Fig. 47",
                    "ref_id": "FIGREF41"
                },
                {
                    "start": 724,
                    "end": 731,
                    "mention": "Fig. 45",
                    "ref_id": "FIGREF39"
                }
            ]
        },
        {
            "text": "Aiming to investigate the trypanocidal activity for pyrazoline\u2013thiazolidinone conjugates the synthesis of new 5-(pyrazolin-1-ylmethylene)-4-thiazolidinones was carried out (Fig. 48\n). Target heterocycles were branched by the methylidene or oxoethylamino-methylidene linker groups. The results of screening against Trypanosoma brucei gambiense allowed to identify 5 compounds with sufficient antitrypanosomal activity (IC50 \u2264 1.2 \u03bcM) and moderate or low cytotoxicity (CC50 = 13.6 -> 184.3 \u03bcM) towards myoblast derived cell line (L-6). Compounds 4.71 (IC50 = 0.6 \u03bcM, CC50 = 175.2 \u03bcM, SI = 292) and 4.72 (IC50 = 0.7 \u03bcM, CC50 = 40 \u03bcM, SI = 57) were significantly more effective than Nifurtimox (IC50 = 4.4 \u03bcM, 78.2 \u03bcM = CC50, SI = 17.8). SAR analysis has been directed on substitution of pyrazoline core and modification of N3-thiazolidinone position (4.73), elongation of linker group (4.74) and rhodanine-isorhodanine isomerism (4.75) [98].",
            "cite_spans": [
                {
                    "start": 933,
                    "end": 937,
                    "mention": "[98]",
                    "ref_id": "BIBREF103"
                }
            ],
            "section": "Antiviral and antiparasitic activity of pyrazole\u2013thiazolidinone hybrids ::: Biological activity of pyrazole-thiazoldinones derivatives and reated heterocyclic hybrids",
            "ref_spans": [
                {
                    "start": 173,
                    "end": 180,
                    "mention": "Fig. 48",
                    "ref_id": "FIGREF42"
                }
            ]
        },
        {
            "text": "The study of antiparasitic activity for pyrazoline\u2013thiazolidinone 4.76 (Fig. 49\n) was carried out towars Trypanosoma cruzi, Trypanosoma b. rhodesiense, Leishmania donovani and Plasmodium falciparum. The results indicated a moderate inhibitory effect on Trypanosoma b. rhodesiense (IC50 = 12 \u03bcg/mL) and L. donovani (IC50 > 30 \u03bcg/mL) and a higher influence on P. falciparum (IC50 > 5 \u03bcg/mL) with cytotoxicity index CC50 > 90 \u03bcg/mL [36].",
            "cite_spans": [
                {
                    "start": 429,
                    "end": 433,
                    "mention": "[36]",
                    "ref_id": "BIBREF35"
                }
            ],
            "section": "Antiviral and antiparasitic activity of pyrazole\u2013thiazolidinone hybrids ::: Biological activity of pyrazole-thiazoldinones derivatives and reated heterocyclic hybrids",
            "ref_spans": [
                {
                    "start": 72,
                    "end": 79,
                    "mention": "Fig. 49",
                    "ref_id": "FIGREF43"
                }
            ]
        },
        {
            "text": "The promising direction for pharmacological investigation of pyrazole\u2013thiazolidinones is the search for new anti-inflammatory agents considering their structural relationship with a known NSAIDs COX-2 inhibitor \u2013 celecoxib. Magda N.A. Nasr and Shehta A. Said studied a group of pyrazoline\u2013thiazolidine/thiazoles 4.79, 4.80 and thiazolidine/thiazole derivatives with hexahydroindazole fragment 4.77, 4.78 and carried out in vivo research on carrageenin induced paw edema at dose of 100 mg/kg using ketoprofen as a reference standard [105]. Results showed that pyrazoline\u2013thiazoles/thiazolidinones 4.79, 4.80 possessed the better anti-inflammatory activity (percentage reduction of paw endema from control group was 17\u201350, and ketoprofen efficiency \u2013 63%) compared with hexahydroindazole 4.77, 4.78 analogues. Comparing the effectiveness of thiazole derivatives (4.78, 4.80) with thiazolidinones (4.77, 4.79) it could be concluded the higher activity of pyrazoline\u2013thiazole hybrids (39\u201350%) (Fig. 50\n).",
            "cite_spans": [
                {
                    "start": 532,
                    "end": 537,
                    "mention": "[105]",
                    "ref_id": "BIBREF7"
                }
            ],
            "section": "Design of new anti-inflammatory agents among pyrazole\u2013thiazolidinones ::: Biological activity of pyrazole-thiazoldinones derivatives and reated heterocyclic hybrids",
            "ref_spans": [
                {
                    "start": 990,
                    "end": 997,
                    "mention": "Fig. 50",
                    "ref_id": "FIGREF45"
                }
            ]
        },
        {
            "text": "Detailed study of pyrazoline\u2013thiazolidinones as potential COX-1 and COX-2 inhibitors allowed to identify highly active compound 4.82 (IC50 = 0.5 \u03bcM for COX-2) with the best selective index (SI = 84.8), which effectiveness was similar to that of Celecoxib. SAR analysis (Fig. 51\n) of the results showed the dependence of COX-2 inhibition on the nature of aryl substituents in the 3 (A-ring) and 5 (B-ring) pyrazoline positions (structure 4.81). Thus, compounds with electron-donor substituents (methyl group) in the para- and meta-positions of the A-ring had better inhibitory effect compared with chlorine. The nature of the substituent in the para-position of the B-cycle also had a significant impact on the inhibitory activity of COX-2 in the order of: H > Br > Cl > F (for R1 = 3,4-Me2, 4.81); H > Me > OMe (for R1 = 3,4-Cl2, 4.81) [31].",
            "cite_spans": [
                {
                    "start": 836,
                    "end": 840,
                    "mention": "[31]",
                    "ref_id": "BIBREF30"
                }
            ],
            "section": "Design of new anti-inflammatory agents among pyrazole\u2013thiazolidinones ::: Biological activity of pyrazole-thiazoldinones derivatives and reated heterocyclic hybrids",
            "ref_spans": [
                {
                    "start": 270,
                    "end": 277,
                    "mention": "Fig. 51",
                    "ref_id": "FIGREF46"
                }
            ]
        },
        {
            "text": "To continue the development of structural analogues of Celecoxib, Adnan A. Bekhit et al. synthesized the series of pyrazole\u2013thiazolidines 4.83\u20134.86 (Fig. 52\n) for anti-inflammatory activity screening using cotton pellet-induced granuloma and carrageenan-induced rat paw edema bioassays. The highly active compounds were tested for their ability to inhibit COX-1/COX-2 as well as ulcerogenic effect and acute toxicity. The first phase of the study (cotton pellet induced granuloma bioassay) allowed to establish that all compounds possessed anti-inflammatory activity with ED50 = 7.86\u201328.42 \u03bcM and the thiazolidine carboxylic acid derivatives (compounds 4.83 \u2013 ED50 = 9.74\u201311.86 \u03bcM, compounds 4.84 \u2013 ED50 = 7.86\u20138.11 \u03bcM) showed better efficiency than Celecoxib (ED50 = 16.74 \u03bcM) and commensurable with Indomethacin (ED50 = 9.64 \u03bcM). Further studies of highly active compounds (4.83 and 4.84) allowed to identify their ability to selective inhibition of COX 2 (IC50 = 0.38\u20130.94 \u03bcM) and reaffirmed their low ulcerogenic action and acute toxicity [39].",
            "cite_spans": [
                {
                    "start": 1043,
                    "end": 1047,
                    "mention": "[39]",
                    "ref_id": "BIBREF38"
                }
            ],
            "section": "Design of new anti-inflammatory agents among pyrazole\u2013thiazolidinones ::: Biological activity of pyrazole-thiazoldinones derivatives and reated heterocyclic hybrids",
            "ref_spans": [
                {
                    "start": 149,
                    "end": 156,
                    "mention": "Fig. 52",
                    "ref_id": "FIGREF47"
                }
            ]
        },
        {
            "text": "Adam M. Gilbert et al. synthesized a series of 5-pyrazolylmethylidene-2-thioxo-4-thiazolidinones 4.87 (Fig. 53\n) as potential inhibitors of ADAMTS-5 (a disintegrin and metalloproteinase with thrombospondin motifs 5) with significant anti-inflammatory activity. Highly active compound 4.88 was identified with the inhibition of ADAMTS-5 IC50 = 1.1 \u03bcM, that demonstrated a strong selectivity (SI > 40) compared to the inhibition of ADAMTS-4. Structural modification of substituents in the pyrazole moiety allowed to establish the main structural criteria to increase the inhibitory effect [83].",
            "cite_spans": [
                {
                    "start": 587,
                    "end": 591,
                    "mention": "[83]",
                    "ref_id": "BIBREF87"
                }
            ],
            "section": "Design of new anti-inflammatory agents among pyrazole\u2013thiazolidinones ::: Biological activity of pyrazole-thiazoldinones derivatives and reated heterocyclic hybrids",
            "ref_spans": [
                {
                    "start": 103,
                    "end": 110,
                    "mention": "Fig. 53",
                    "ref_id": "FIGREF48"
                }
            ]
        },
        {
            "text": "Amal M. Youssef et al. carried out the synthesis of 5-((1,3-aryl-1H-pyrazol-4-yl)methylene)thiazolidine-2,4-diones as potential anti-inflammatory and neuroprotective agents [79]. The studies conducted in vitro and in vivo allowed to identify a group of highly active anti-inflammatory compounds with a low ulcerogenic impact and satisfactory toxicometry parameters. Based on in vitro experiments four compounds (4.89) were selected for in vivo studies according to screening protocols: the formalin-induced paw edema and turpentine oil-induced granuloma pouch bioassays. It was established that the tested compounds showed activity comparable to Celecoxib at a concentration of 20 mg/kg. The introduction of benzyl moiety in position 3 of thiazolidinone was accompanied by the loss of anti-inflammatory activity (Fig. 54\n).",
            "cite_spans": [
                {
                    "start": 173,
                    "end": 177,
                    "mention": "[79]",
                    "ref_id": "BIBREF82"
                }
            ],
            "section": "Design of new anti-inflammatory agents among pyrazole\u2013thiazolidinones ::: Biological activity of pyrazole-thiazoldinones derivatives and reated heterocyclic hybrids",
            "ref_spans": [
                {
                    "start": 813,
                    "end": 820,
                    "mention": "Fig. 54",
                    "ref_id": "FIGREF49"
                }
            ]
        },
        {
            "text": "This review article presents the rational approaches to the design of chemotherapeutic agents based on molecular hybridization of pharmacologically attractive thiazolidine and pyrazole/pyrazoline heterocycles. Based on linkage of target heterocyclic cores the reviewed hybrids were classified as 2-, 3- and 5-pyrazole/pyrazoline-substituted thiazolidines. The basic approaches for the synthesis of pyrazole-thiazolidinones have been provided by a combination of two \u201csmall\u201d molecules via aminolysis, acylation reactions and Knoevenagel procedure or heterocyclization of monocyclic compounds via the [2+3]-cyclization reaction yielding the series of non-condensed bicyclic systems. The review of biological applications was focused on SAR analysis and mechanistic insights of thiazolidine\u2013pyrazole hybrids. Molecular hybridization as a tool of medicinal chemistry has been successfully used for design of biologically active conjugates with antitumor activity, including inhibition of necroptosis, CDC25V phosphatase, TNF-\u03b1\u2013TNFRc1 interaction or activation of pro-apoptotic BAX, antimicrobial, antifungal, antiviral and antiparasitic applications, as well as anti-inflammatory properties as inhibitors of COX or ADAMTS-5 enzymes.",
            "cite_spans": [],
            "section": "Conclusions",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "FIGREF0": {
            "text": "Fig.\u00a01: Heterocycles for pyrazole/pyrazoline\u2013thiazole/thiazolidine hybridization and the most promising conjugates.",
            "type": "figure"
        },
        "FIGREF1": {
            "text": "Fig.\u00a010: Pyrazole-substituted thiosemicarbazides in synthesis of pyrazole\u2013thiazole hybrids.",
            "type": "figure"
        },
        "FIGREF2": {
            "text": "Fig.\u00a011: Synthesis of 3-diazole-substituted 4-thiazolidinones.",
            "type": "figure"
        },
        "FIGREF3": {
            "text": "Fig.\u00a012: Synthesis and modification of 3-pyrazole-substituted rhodanines.",
            "type": "figure"
        },
        "FIGREF4": {
            "text": "Fig.\u00a013: \u03b1-Mercaptocarboxylic acids reagent in the synthesis of 3-subtituted thiazolidinones.",
            "type": "figure"
        },
        "FIGREF5": {
            "text": "Fig.\u00a014: Holmberg synthesis for benzopyrazole\u2013rhodanine.",
            "type": "figure"
        },
        "FIGREF6": {
            "text": "Fig.\u00a015: Synthesis of pyrazole\u2013thiazolidinone conjugates via acylation reaction.",
            "type": "figure"
        },
        "FIGREF7": {
            "text": "Fig.\u00a016: Synthesis of pyrazoline\u2013azolidinone conjugates via alkylation reaction.",
            "type": "figure"
        },
        "FIGREF8": {
            "text": "Fig.\u00a017: Knoevenagel and diazo coupling reactions for synthesis of pyrazole\u2013thiazolidinones.",
            "type": "figure"
        },
        "FIGREF9": {
            "text": "Fig.\u00a018: Synthesis of pyrazoline\u2013indoline\u2013thiazolidinone conjugates.",
            "type": "figure"
        },
        "FIGREF10": {
            "text": "Fig.\u00a019: Synthesis of pyrazolone\u2013thiazolidinone conjugates.",
            "type": "figure"
        },
        "FIGREF11": {
            "text": "Fig.\u00a02: Synthesis of pyrazoline\u2013thiazolidinones via [2+3]-cyclization reactions.",
            "type": "figure"
        },
        "FIGREF12": {
            "text": "Fig.\u00a020: Chromene ring-transformation reactions in synthesis of thiazolidinone\u2013diazole hybrids.",
            "type": "figure"
        },
        "FIGREF13": {
            "text": "Fig.\u00a021: Synthesis of 5-pyrazole-substituted thiazolidinones via [2+3]-cyclocondensation.",
            "type": "figure"
        },
        "FIGREF14": {
            "text": "Fig.\u00a022: Alternative approaches for the synthesis of thiazolidinone\u2013pyrazolones.",
            "type": "figure"
        },
        "FIGREF15": {
            "text": "Fig.\u00a023: Synthesis and modification of pyrazoline\u2013thiazolidinones.",
            "type": "figure"
        },
        "FIGREF16": {
            "text": "Fig.\u00a024: Synthesis and alkylation of thiazolidinone\u2013pyrazolines 3.16.",
            "type": "figure"
        },
        "FIGREF17": {
            "text": "Fig.\u00a025: Synthesis of 5-pyrazoline substituted thiazolidinones.",
            "type": "figure"
        },
        "FIGREF18": {
            "text": "Fig.\u00a026: Synthesis of pyrazoline\u2013rhodanine conjugates with oxoethylamino-methylene linker group.",
            "type": "figure"
        },
        "FIGREF19": {
            "text": "Fig.\u00a027: Antitumor activity for pyrazoline\u2013thiazolidinone based hybrids.",
            "type": "figure"
        },
        "FIGREF20": {
            "text": "Fig.\u00a028: Isatin-based conjugates with antitumor activity.",
            "type": "figure"
        },
        "FIGREF21": {
            "text": "Fig.\u00a029: Thiazole\u2013pyrazoline hybrids with antitumor activity.",
            "type": "figure"
        },
        "FIGREF22": {
            "text": "Fig.\u00a03: Three-component one-pot reactions in synthesis of 2-pyrazolinyl-4-thiazolidinones.",
            "type": "figure"
        },
        "FIGREF23": {
            "text": "Fig.\u00a030: Antitumor thiazolidinone/thiazole derivatives with pyrazoline moiety in 2 position.",
            "type": "figure"
        },
        "FIGREF24": {
            "text": "Fig.\u00a031: Antitumor azolidine-pyrazolines with thiazolidinone/thiazole fragments.",
            "type": "figure"
        },
        "FIGREF25": {
            "text": "Fig.\u00a032: Antitumor activity of pyrazole-thiazolidinone\u2013triazoles on lung cancer.",
            "type": "figure"
        },
        "FIGREF26": {
            "text": "Fig.\u00a033: 5-Pyrazoline-substituted pseudothiohydantoines as promising necroptosis inhibitors.",
            "type": "figure"
        },
        "FIGREF27": {
            "text": "Fig.\u00a034: Selective antitumor activity of pyrazole-rhodanine 4.25.",
            "type": "figure"
        },
        "FIGREF28": {
            "text": "Fig.\u00a035: Bis-thiazolone with indazole fragment as potential inhibitor of CDC25V phosphatase.",
            "type": "figure"
        },
        "FIGREF29": {
            "text": "Fig.\u00a036: Antitumor activity of 4-thiazolidinones with pyrazolines in 5 position.",
            "type": "figure"
        },
        "FIGREF30": {
            "text": "Fig.\u00a037: Pyrazoline\u2013thiazolidinone hybrids with antimicrobial activity.",
            "type": "figure"
        },
        "FIGREF31": {
            "text": "Fig.\u00a038: SAR analysis of antimicrobial pyrazole\u2013thiazolidinone hybrids.",
            "type": "figure"
        },
        "FIGREF32": {
            "text": "Fig.\u00a039: Antimicrobial and antifungal pyrazole\u2013thiazolidinones/thiazoles, coupled by hydrazone linker group.",
            "type": "figure"
        },
        "FIGREF33": {
            "text": "Fig.\u00a04: Thioglycolic acid reagent in thiazolidinone ring-formation reactions.",
            "type": "figure"
        },
        "FIGREF34": {
            "text": "Fig.\u00a040: Antimicrobial and antifungal activity for polyheterocyclic systems based on pyrazole-thiazolidinones/thiazoles.",
            "type": "figure"
        },
        "FIGREF35": {
            "text": "Fig.\u00a041: Antimicrobial thiazolidines/thiazoles with 5-pyrazolone fragment.",
            "type": "figure"
        },
        "FIGREF36": {
            "text": "Fig.\u00a042: 3-Pyrazolinyl-4-thiazolidinones with antimicrobial activity.",
            "type": "figure"
        },
        "FIGREF37": {
            "text": "Fig.\u00a043: Pyrazole-pyrimidine\u2013thiazolidinones as promising antimicrobial agents.",
            "type": "figure"
        },
        "FIGREF38": {
            "text": "Fig.\u00a044: Antimicrobial activity of 4-thiazolidinones with pyrazole in 5 position.",
            "type": "figure"
        },
        "FIGREF39": {
            "text": "Fig.\u00a045: Structure-antimicrobial activity relationship for pyrazole\u2013rhodanine derivatives.",
            "type": "figure"
        },
        "FIGREF40": {
            "text": "Fig.\u00a046: Pyrazole/pyrazolines\u2013thiazolidinone/thiazoles with antiviral activity.",
            "type": "figure"
        },
        "FIGREF41": {
            "text": "Fig.\u00a047: Antiviral and antitrypanosomal 5-pyrazoline substituted 4-thiazolidinones.",
            "type": "figure"
        },
        "FIGREF42": {
            "text": "Fig.\u00a048: SAR for trypanocidal 5-(pyrazolin-1-ylmethylene)-4-thiazolidinones.",
            "type": "figure"
        },
        "FIGREF43": {
            "text": "Fig.\u00a049: Pyrazoline\u2013thiazolidinone hybrid with antiparasitic activity.",
            "type": "figure"
        },
        "FIGREF44": {
            "text": "Fig.\u00a05: Example of pyrazole formation in the synthesis of pyrazole-thiazolines.",
            "type": "figure"
        },
        "FIGREF45": {
            "text": "Fig.\u00a050: Thiazolidinones and thiazoles with pyrazoline fragments as anti-inflammatory agents.",
            "type": "figure"
        },
        "FIGREF46": {
            "text": "Fig.\u00a051: Pyrazoline\u2013thiazolidinone hybrids as COX-2 inhibitors.",
            "type": "figure"
        },
        "FIGREF47": {
            "text": "Fig.\u00a052: Pyrazole-thiazolidine hybrids as COX-2 inhibitors.",
            "type": "figure"
        },
        "FIGREF48": {
            "text": "Fig.\u00a053: ADAMTS-5 inhibitors among pyrazole-thiazolidinone hybrids.",
            "type": "figure"
        },
        "FIGREF49": {
            "text": "Fig.\u00a054: Pyrazole\u2013thiazolidinones with anti-inflammatory activity.",
            "type": "figure"
        },
        "FIGREF50": {
            "text": "Fig.\u00a06: Synthesis of pyrazole\u2013thiazolidinones with imine linker group.",
            "type": "figure"
        },
        "FIGREF51": {
            "text": "Fig.\u00a07: Synthesis of diazole\u2013thiazolidinones/thiazolidines with sulfonylimine linker group.",
            "type": "figure"
        },
        "FIGREF52": {
            "text": "Fig.\u00a08: Aminolysis reaction in synthesis of pyrazole\u2013thiazolidinones.",
            "type": "figure"
        },
        "FIGREF53": {
            "text": "Fig.\u00a09: Synthesis of pyrazole derivatives with thiazolidinone, imidazolidine and thiazoline fragments in molecules.",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Advances in the development of hybrid anticancer drugs",
            "authors": [
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Fortin",
                    "suffix": ""
                },
                {
                    "first": "G.",
                    "middle": [],
                    "last": "Berube",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Expert Opin. Drug Discov.",
            "volume": "8",
            "issn": "",
            "pages": "1547-1577",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF1": {
            "title": "Recent developments and biological activities of thiazolidinone derivatives: a review",
            "authors": [
                {
                    "first": "A.K.",
                    "middle": [],
                    "last": "Jain",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Vaidya",
                    "suffix": ""
                },
                {
                    "first": "V.",
                    "middle": [],
                    "last": "Ravichandran",
                    "suffix": ""
                },
                {
                    "first": "S.K.",
                    "middle": [],
                    "last": "Kashaw",
                    "suffix": ""
                },
                {
                    "first": "R.K.",
                    "middle": [],
                    "last": "Agrawal",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Bioorg. Med. Chem.",
            "volume": "20",
            "issn": "",
            "pages": "3378-3395",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "Synthesis of novel linked pyrazolyl-thiazolidinone heterocycles as potent antibacterial agents",
            "authors": [
                {
                    "first": "C.S.",
                    "middle": [],
                    "last": "Reddy",
                    "suffix": ""
                },
                {
                    "first": "G.R.",
                    "middle": [],
                    "last": "Kumar",
                    "suffix": ""
                },
                {
                    "first": "M.V.",
                    "middle": [],
                    "last": "Devi",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Nagaraj",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Acta Chim. Slov.",
            "volume": "58",
            "issn": "",
            "pages": "576-581",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "Design and synthesis of spiro[indole-thiazolidine]spiro[indole-pyrans] as antimicrobial agents",
            "authors": [
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Sakhuja",
                    "suffix": ""
                },
                {
                    "first": "S.S.",
                    "middle": [],
                    "last": "Panda",
                    "suffix": ""
                },
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Khanna",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Khurana",
                    "suffix": ""
                },
                {
                    "first": "S.C.",
                    "middle": [],
                    "last": "Jain",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Bioorg. Med. Chem. Lett.",
            "volume": "21",
            "issn": "",
            "pages": "5465-5469",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF4": {
            "title": "Synthesis and antibacterial evaluation of rhodanine-based 5-aryloxy pyrazoles against selected methicillin resistant and quinoloneresistant Staphylococcus aureus (MRSA and QRSA)",
            "authors": [
                {
                    "first": "M.-X.",
                    "middle": [],
                    "last": "Song",
                    "suffix": ""
                },
                {
                    "first": "C.-J.",
                    "middle": [],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "X.-Q.",
                    "middle": [],
                    "last": "Deng",
                    "suffix": ""
                },
                {
                    "first": "L.-P.",
                    "middle": [],
                    "last": "Sun",
                    "suffix": ""
                },
                {
                    "first": "Y.",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Hong",
                    "suffix": ""
                },
                {
                    "first": "Y.-J.",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "Y.",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "Z.-Y.",
                    "middle": [],
                    "last": "Wei",
                    "suffix": ""
                },
                {
                    "first": "M.-J.",
                    "middle": [],
                    "last": "Jin",
                    "suffix": ""
                },
                {
                    "first": "H.-R.",
                    "middle": [],
                    "last": "Piao",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Eur. J. Med. Chem.",
            "volume": "60",
            "issn": "",
            "pages": "376-385",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF5": {
            "title": "Synthesis of novel 1,3-diaryl pyrazole derivatives bearing rhodanine-3-fatty acid moieties as potential antibacterial agents",
            "authors": [
                {
                    "first": "L.-L.",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "C.-J.",
                    "middle": [],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "L.-P.",
                    "middle": [],
                    "last": "Sun",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Miao",
                    "suffix": ""
                },
                {
                    "first": "H.-R.",
                    "middle": [],
                    "last": "Piao",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Eur. J. Med. Chem.",
            "volume": "48",
            "issn": "",
            "pages": "174-178",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF6": {
            "title": "Synthesis of thiazolone-based sulfonamides as inhibitors of HCV NS5B polymerase",
            "authors": [
                {
                    "first": "Y.",
                    "middle": [],
                    "last": "Ding",
                    "suffix": ""
                },
                {
                    "first": "K.L.",
                    "middle": [],
                    "last": "Smith",
                    "suffix": ""
                },
                {
                    "first": "C.V.N.S.",
                    "middle": [],
                    "last": "Varaprasad",
                    "suffix": ""
                },
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Chang",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Alexander",
                    "suffix": ""
                },
                {
                    "first": "N.",
                    "middle": [],
                    "last": "Yao",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Bioorg. Med. Chem. Lett.",
            "volume": "17",
            "issn": "",
            "pages": "841-845",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF7": {
            "title": "Novel 3,3a,4,5,6,7-hexahydroindazole and arylthiazolylpyrazoline derivatives as anti-inflammatory agents",
            "authors": [
                {
                    "first": "M.N.A.",
                    "middle": [],
                    "last": "Nasr",
                    "suffix": ""
                },
                {
                    "first": "S.A.",
                    "middle": [],
                    "last": "Said",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Arch. Pharm. Pharm. Med. Chem.",
            "volume": "336",
            "issn": "",
            "pages": "551-559",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF8": {
            "title": "4,5-Dihydro-1H-pyrazole: an indispensable scaffold",
            "authors": [
                {
                    "first": "J.M.",
                    "middle": [],
                    "last": "Ale",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Kumar",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "J.\u00a0Enzyme Inhib. Med. Chem.",
            "volume": "8",
            "issn": "",
            "pages": "1547-1577",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF9": {
            "title": "Recent advances in the therapeutic applications of pyrazolines",
            "authors": [
                {
                    "first": "M.R.",
                    "middle": [],
                    "last": "Shaaban",
                    "suffix": ""
                },
                {
                    "first": "A.S.",
                    "middle": [],
                    "last": "Mayhoub",
                    "suffix": ""
                },
                {
                    "first": "A.M.",
                    "middle": [],
                    "last": "Farag",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Expert Opin. Ther. Pat.",
            "volume": "22",
            "issn": "",
            "pages": "253-291",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF10": {
            "title": "Insecticidal lead identification by screening benzopyrano[4,3-c]-pyrazol-3(2H)-ones library constructed from multiple-parallel synthesis under microwave irradiation",
            "authors": [
                {
                    "first": "Z.-Z.",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "G.-F.",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Bioorg. Med. Chem.",
            "volume": "14",
            "issn": "",
            "pages": "8666-8674",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF11": {
            "title": "Synthesis, fungicidal, and insecticidal activities of \u03b2-methoxyacrylate-containing N-acetyl pyrazoline derivatives",
            "authors": [
                {
                    "first": "P.-L.",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "F.",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "M.-Z.",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "Z.-M.",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "W.",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "G.-F.",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "J.\u00a0Agric. Food Chem.",
            "volume": "56",
            "issn": "",
            "pages": "10767-10773",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF12": {
            "title": "Subnanomolar inhibitor of cytochrome bc1 complex designed by optimizing interaction with conformationally flexible residues",
            "authors": [
                {
                    "first": "P.-L.",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "X.-L.",
                    "middle": [],
                    "last": "Zhu",
                    "suffix": ""
                },
                {
                    "first": "X.",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "C.-G.",
                    "middle": [],
                    "last": "Zhan",
                    "suffix": ""
                },
                {
                    "first": "J.-W.",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "G.-F.",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "J.\u00a0Am. Chem. Soc.",
            "volume": "132",
            "issn": "",
            "pages": "185-194",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF13": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF14": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF15": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF16": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF17": {
            "title": "Promise and challenges in drug discovery and development of hybrid anticancer drugs",
            "authors": [
                {
                    "first": "L.K.",
                    "middle": [],
                    "last": "Gediya",
                    "suffix": ""
                },
                {
                    "first": "V.C.",
                    "middle": [],
                    "last": "Njar",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Expert Opin. Drug Discov.",
            "volume": "4",
            "issn": "",
            "pages": "1099-1111",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF18": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF19": {
            "title": "Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-\u03b1",
            "authors": [
                {
                    "first": "P.H.",
                    "middle": [],
                    "last": "Carter",
                    "suffix": ""
                },
                {
                    "first": "P.A.",
                    "middle": [],
                    "last": "Scherle",
                    "suffix": ""
                },
                {
                    "first": "J.A.",
                    "middle": [],
                    "last": "Muckelbauer",
                    "suffix": ""
                },
                {
                    "first": "M.E.",
                    "middle": [],
                    "last": "Voss",
                    "suffix": ""
                },
                {
                    "first": "R.-Q.",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "L.A.",
                    "middle": [],
                    "last": "Thompson",
                    "suffix": ""
                },
                {
                    "first": "A.J.",
                    "middle": [],
                    "last": "Tebben",
                    "suffix": ""
                },
                {
                    "first": "K.A.",
                    "middle": [],
                    "last": "Solomon",
                    "suffix": ""
                },
                {
                    "first": "Y.C.",
                    "middle": [],
                    "last": "Lo",
                    "suffix": ""
                },
                {
                    "first": "Z.",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Strzemienski",
                    "suffix": ""
                },
                {
                    "first": "G.",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "N.",
                    "middle": [],
                    "last": "Falahatpisheh",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "Z.",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "N.A.",
                    "middle": [],
                    "last": "Farrow",
                    "suffix": ""
                },
                {
                    "first": "K.",
                    "middle": [],
                    "last": "Ramnarayan",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "D.",
                    "middle": [],
                    "last": "Rideout",
                    "suffix": ""
                },
                {
                    "first": "V.",
                    "middle": [],
                    "last": "Yalamoori",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Domaille",
                    "suffix": ""
                },
                {
                    "first": "D.J.",
                    "middle": [],
                    "last": "Underwood",
                    "suffix": ""
                },
                {
                    "first": "J.M.",
                    "middle": [],
                    "last": "Trzaskos",
                    "suffix": ""
                },
                {
                    "first": "S.M.",
                    "middle": [],
                    "last": "Friedman",
                    "suffix": ""
                },
                {
                    "first": "R.C.",
                    "middle": [],
                    "last": "Newton",
                    "suffix": ""
                },
                {
                    "first": "C.P.",
                    "middle": [],
                    "last": "Decicco",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Proc. Natl. Acad. Sci. U. S. A.",
            "volume": "98",
            "issn": "",
            "pages": "11879-11884",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF20": {
            "title": "Rhodanine carboxylic acids as novel inhibitors of histoneacetyltransferases",
            "authors": [
                {
                    "first": "S.D.",
                    "middle": [],
                    "last": "Furdas",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Shekfeh",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Kannan",
                    "suffix": ""
                },
                {
                    "first": "W.",
                    "middle": [],
                    "last": "Sippl",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Jung",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Med. Chem. Commun.",
            "volume": "3",
            "issn": "",
            "pages": "305-311",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF21": {
            "title": "Design and synthesis of new 4-pyrazolin-3-yl-1,2,3-triazoles and 1,2,3-triazol-4-yl-pyrazolin-1-ylthiazoles as potential antimicrobial agents",
            "authors": [
                {
                    "first": "B.F.",
                    "middle": [],
                    "last": "Abdel-Wahab",
                    "suffix": ""
                },
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Abdel-Latif",
                    "suffix": ""
                },
                {
                    "first": "H.A.",
                    "middle": [],
                    "last": "Mohamed",
                    "suffix": ""
                },
                {
                    "first": "G.E.A.",
                    "middle": [],
                    "last": "Awad",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Eur. J. Med. Chem.",
            "volume": "52",
            "issn": "",
            "pages": "263-268",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF22": {
            "title": "Synthesis and antimicrobial activity of some 3,5-diaryl-4,5-dihydropyrazole derivatives",
            "authors": [
                {
                    "first": "M.M.",
                    "middle": [],
                    "last": "El-Enany",
                    "suffix": ""
                },
                {
                    "first": "S.E.M.",
                    "middle": [],
                    "last": "El-Meligie",
                    "suffix": ""
                },
                {
                    "first": "N.A.",
                    "middle": [],
                    "last": "Abdou",
                    "suffix": ""
                },
                {
                    "first": "H.B.",
                    "middle": [],
                    "last": "El-Nassan",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Orient. J. Chem.",
            "volume": "26",
            "issn": "",
            "pages": "1265-1270",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF23": {
            "title": "Synthesis of new quinoline-2-pyrazoline-based thiazolinone derivatives as potential antimicrobial agents",
            "authors": [
                {
                    "first": "N.C.",
                    "middle": [],
                    "last": "Desai",
                    "suffix": ""
                },
                {
                    "first": "V.V.",
                    "middle": [],
                    "last": "Joshi",
                    "suffix": ""
                },
                {
                    "first": "K.M.",
                    "middle": [],
                    "last": "Rajpara",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Med. Chem. Res.",
            "volume": "22",
            "issn": "",
            "pages": "3663-3674",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF24": {
            "title": "Facile synthesis of novel fluorine containing pyrazole based thiazole derivatives and evaluation of antimicrobial activity",
            "authors": [
                {
                    "first": "N.C.",
                    "middle": [],
                    "last": "Desai",
                    "suffix": ""
                },
                {
                    "first": "V.V.",
                    "middle": [],
                    "last": "Joshi",
                    "suffix": ""
                },
                {
                    "first": "K.M.",
                    "middle": [],
                    "last": "Rajpara",
                    "suffix": ""
                },
                {
                    "first": "H.V.",
                    "middle": [],
                    "last": "Vaghani",
                    "suffix": ""
                },
                {
                    "first": "H.M.",
                    "middle": [],
                    "last": "Satodiya",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "J.\u00a0Fluor. Chem.",
            "volume": "142",
            "issn": "",
            "pages": "67-78",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF25": {
            "title": "Synthesis and characterization of some new quinoline based derivatives endowed with broad spectrum antimicrobial potency",
            "authors": [
                {
                    "first": "N.C.",
                    "middle": [],
                    "last": "Desai",
                    "suffix": ""
                },
                {
                    "first": "K.M.",
                    "middle": [],
                    "last": "Rajpara",
                    "suffix": ""
                },
                {
                    "first": "V.V.",
                    "middle": [],
                    "last": "Joshi",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Bioorg. Med. Chem. Lett.",
            "volume": "22",
            "issn": "",
            "pages": "6871-6875",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF26": {
            "title": "Discovery and modification of sulfur-containing heterocyclic pyrazoline derivatives as potential novel class of b-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors",
            "authors": [
                {
                    "first": "Y.-S.",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "F.",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Gao",
                    "suffix": ""
                },
                {
                    "first": "Y.-B.",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "X.-L.",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "J.-F.",
                    "middle": [],
                    "last": "Tang",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Sun",
                    "suffix": ""
                },
                {
                    "first": "H.-B.",
                    "middle": [],
                    "last": "Gong",
                    "suffix": ""
                },
                {
                    "first": "H.-L.",
                    "middle": [],
                    "last": "Zhu",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Bioorg. Med. Chem. Lett.",
            "volume": "22",
            "issn": "",
            "pages": "4619-4624",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF27": {
            "title": "Synthesis and antiviral activity of new pyrazole and thiazole derivatives",
            "authors": [
                {
                    "first": "O.I.",
                    "middle": [],
                    "last": "El-Sabbagh",
                    "suffix": ""
                },
                {
                    "first": "M.M.",
                    "middle": [],
                    "last": "Baraka",
                    "suffix": ""
                },
                {
                    "first": "S.M.",
                    "middle": [],
                    "last": "Ibrahim",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Pannecouque",
                    "suffix": ""
                },
                {
                    "first": "G.",
                    "middle": [],
                    "last": "Andrei",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Snoeck",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Balzarini",
                    "suffix": ""
                },
                {
                    "first": "A.A.",
                    "middle": [],
                    "last": "Rashad",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Eur. J. Med. Chem.",
            "volume": "44",
            "issn": "",
            "pages": "3746-3753",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF28": {
            "title": "Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids",
            "authors": [
                {
                    "first": "K.",
                    "middle": [],
                    "last": "Nepali",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Sharma",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Sharma",
                    "suffix": ""
                },
                {
                    "first": "P.M.S.",
                    "middle": [],
                    "last": "Bedi",
                    "suffix": ""
                },
                {
                    "first": "K.L.",
                    "middle": [],
                    "last": "Dhar",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Eur. J. Med. Chem.",
            "volume": "77",
            "issn": "",
            "pages": "422-487",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF29": {
            "title": "Synthesis, anticancer and antiviral activity of new 2-pyrazoline substituted 4-thiazolidinones",
            "authors": [
                {
                    "first": "D.",
                    "middle": [],
                    "last": "Havrylyuk",
                    "suffix": ""
                },
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Zimenkovsky",
                    "suffix": ""
                },
                {
                    "first": "O.",
                    "middle": [],
                    "last": "Vasylenko",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Lesyk",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "J.\u00a0Heterocycl. Chem.",
            "volume": "50",
            "issn": "",
            "pages": "E55-E62",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF30": {
            "title": "Synthesis, biological evaluation and molecular modeling of dihydro-pyrazolyl-thiazolinone derivatives as potential COX-2 inhibitors",
            "authors": [
                {
                    "first": "K.-M.",
                    "middle": [],
                    "last": "Qiu",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Yan",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Xing",
                    "suffix": ""
                },
                {
                    "first": "H.-H.",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "H.-E.",
                    "middle": [],
                    "last": "Cui",
                    "suffix": ""
                },
                {
                    "first": "H.-B.",
                    "middle": [],
                    "last": "Gong",
                    "suffix": ""
                },
                {
                    "first": "H.-L.",
                    "middle": [],
                    "last": "Zhu",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Bioorg. Med. Chem.",
            "volume": "20",
            "issn": "",
            "pages": "6648-6654",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF31": {
            "title": "Synthesis of new 4-thiazolidinone-, pyrazoline-, and isatin-based conjugates with promising antitumor activity",
            "authors": [
                {
                    "first": "D.",
                    "middle": [],
                    "last": "Havrylyuk",
                    "suffix": ""
                },
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Zimenkovsky",
                    "suffix": ""
                },
                {
                    "first": "O.",
                    "middle": [],
                    "last": "Vasylenko",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Gzella",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Lesyk",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "J.\u00a0Med. Chem.",
            "volume": "55",
            "issn": "",
            "pages": "8630-8641",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF32": {
            "title": "Synthesis of novel thiazolone-based compounds containing pyrazoline moiety and evaluation of their anticancer activity",
            "authors": [
                {
                    "first": "D.",
                    "middle": [],
                    "last": "Havrylyuk",
                    "suffix": ""
                },
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Zimenkovsky",
                    "suffix": ""
                },
                {
                    "first": "O.",
                    "middle": [],
                    "last": "Vasylenko",
                    "suffix": ""
                },
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Zaprutko",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Gzella",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Lesyk",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Eur. J. Med. Chem.",
            "volume": "44",
            "issn": "",
            "pages": "1396-1404",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF33": {
            "title": "Synthesis, characterization, and biological evaluation of certain 1,3-thiazolone derivatives bearing pyrazoline moiety as potential anti-breast cancer agents",
            "authors": [
                {
                    "first": "N.A.",
                    "middle": [],
                    "last": "Khalil",
                    "suffix": ""
                },
                {
                    "first": "E.M.",
                    "middle": [],
                    "last": "Ahmed",
                    "suffix": ""
                },
                {
                    "first": "H.B.",
                    "middle": [],
                    "last": "El-Nassan",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Med. Chem. Res.",
            "volume": "22",
            "issn": "",
            "pages": "1021-1027",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF34": {
            "title": "Synthesis and biological evaluation of novel 4,5-dihydropyrazole derivatives as potent anticancer and antimicrobial agents",
            "authors": [
                {
                    "first": "Y.R.",
                    "middle": [],
                    "last": "Prasad",
                    "suffix": ""
                },
                {
                    "first": "G.V.S.",
                    "middle": [],
                    "last": "Kumar",
                    "suffix": ""
                },
                {
                    "first": "S.M.",
                    "middle": [],
                    "last": "Chandrashekar",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Med. Chem. Res.",
            "volume": "22",
            "issn": "",
            "pages": "2061-2078",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF35": {
            "title": "New 1,3-thiazoles and 1,3-thiazines from 1-thiocarbamoylpyrazoles",
            "authors": [
                {
                    "first": "W.",
                    "middle": [],
                    "last": "Seebacher",
                    "suffix": ""
                },
                {
                    "first": "F.",
                    "middle": [],
                    "last": "Belaj",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Saf",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Brun",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Weis",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Monatsh. Chem.",
            "volume": "134",
            "issn": "",
            "pages": "1623-1628",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF36": {
            "title": "Reaction of acetylenedicarboxylic acids esters with 4,5-dihydro-1H-pyrazole-1-carbothioamides and 3,4,5,6-tetrahydro-2H-1,2,4-triazepine-3-thiones",
            "authors": [
                {
                    "first": "N.A.",
                    "middle": [],
                    "last": "Danilkina",
                    "suffix": ""
                },
                {
                    "first": "L.E.",
                    "middle": [],
                    "last": "Mikhaylov",
                    "suffix": ""
                },
                {
                    "first": "B.A.",
                    "middle": [],
                    "last": "Ivin",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Chem. Heterocycl. Comp.",
            "volume": "47",
            "issn": "",
            "pages": "886-900",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF37": {
            "title": "New direction in the reaction of thiocarboxamides with N-substituted maleimides",
            "authors": [
                {
                    "first": "R.V.",
                    "middle": [],
                    "last": "Rudenko",
                    "suffix": ""
                },
                {
                    "first": "S.A.",
                    "middle": [],
                    "last": "Komykhov",
                    "suffix": ""
                },
                {
                    "first": "S.M.",
                    "middle": [],
                    "last": "Desenko",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Chem. Heterocycl. Comp.",
            "volume": "45",
            "issn": "",
            "pages": "1017-1018",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF38": {
            "title": "Synthesis and biological evaluation of some thiazolylpyrazole derivatives as dual anti-inflammatory antimicrobial agents",
            "authors": [
                {
                    "first": "A.A.",
                    "middle": [],
                    "last": "Bekhit",
                    "suffix": ""
                },
                {
                    "first": "H.T.Y.",
                    "middle": [],
                    "last": "Fahmy",
                    "suffix": ""
                },
                {
                    "first": "S.A.F.",
                    "middle": [],
                    "last": "Rostom",
                    "suffix": ""
                },
                {
                    "first": "A.E.-D.A.",
                    "middle": [],
                    "last": "Bekhit",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Eur. J. Med. Chem.",
            "volume": "45",
            "issn": "",
            "pages": "6027-6038",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF39": {
            "title": "Synthesis, biological activity of thiazolidinones bearing indoline moiety and isatin based hybrids",
            "authors": [
                {
                    "first": "D.",
                    "middle": [],
                    "last": "Havrylyuk",
                    "suffix": ""
                },
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Zimenkovsky",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Lesyk",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Mini Rev. Org. Chem.",
            "volume": "12",
            "issn": "",
            "pages": "66-87",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF40": {
            "title": "Synthesis, characterization, anticancer, and antioxidant activity of some new thiazolidin-4-ones in MCF-7 cells",
            "authors": [
                {
                    "first": "A.M.",
                    "middle": [],
                    "last": "Isloor",
                    "suffix": ""
                },
                {
                    "first": "D.",
                    "middle": [],
                    "last": "Sunil",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Shetty",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Malladi",
                    "suffix": ""
                },
                {
                    "first": "K.S.R.",
                    "middle": [],
                    "last": "Pai",
                    "suffix": ""
                },
                {
                    "first": "N.",
                    "middle": [],
                    "last": "Maliyakkl",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Med. Chem. Res.",
            "volume": "22",
            "issn": "",
            "pages": "758-767",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF41": {
            "title": "Synthesis of 3-(1-benzyl-1H-benzo[d]imidazol-2-yl amino)-2-(3-aryl-1-phenyl-1H-pyrazol-4-yl)thiazolidin-4-ones and their antimicrobial activities",
            "authors": [
                {
                    "first": "S.B.",
                    "middle": [],
                    "last": "Patil",
                    "suffix": ""
                },
                {
                    "first": "N.M.",
                    "middle": [],
                    "last": "Goudgaon",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Int. J. Pharm. Sci. Res.",
            "volume": "1",
            "issn": "",
            "pages": "50-56",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF42": {
            "title": "Synthesis of some new heterocyclic compounds from benzopyrano[2,3-c]pyrazol-3-one derivatives",
            "authors": [
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Khodairy",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Synth. Commun.",
            "volume": "31",
            "issn": "",
            "pages": "2697-2712",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF43": {
            "title": "Polyfluoroalkylated 1,3-thiazolines: synthesis from polyfluoro-2,3-epoxyalkanes",
            "authors": [
                {
                    "first": "L.V.",
                    "middle": [],
                    "last": "Saloutina",
                    "suffix": ""
                },
                {
                    "first": "A.Ya.",
                    "middle": [],
                    "last": "Zapevalov",
                    "suffix": ""
                },
                {
                    "first": "M.I.",
                    "middle": [],
                    "last": "Kodess",
                    "suffix": ""
                },
                {
                    "first": "V.I.",
                    "middle": [],
                    "last": "Saloutin",
                    "suffix": ""
                },
                {
                    "first": "G.G.",
                    "middle": [],
                    "last": "Aleksandrov",
                    "suffix": ""
                },
                {
                    "first": "O.N.",
                    "middle": [],
                    "last": "Chupakhin",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "J.\u00a0Fluor. Chem.",
            "volume": "104",
            "issn": "",
            "pages": "155-165",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF44": {
            "title": "Polyfluoro-2,3-epoxyalkanes in reactions with thiourea and thiosemicarbazide",
            "authors": [
                {
                    "first": "L.V.",
                    "middle": [],
                    "last": "Saloutina",
                    "suffix": ""
                },
                {
                    "first": "A.Ya.",
                    "middle": [],
                    "last": "Zapevalov",
                    "suffix": ""
                },
                {
                    "first": "M.I.",
                    "middle": [],
                    "last": "Kodess",
                    "suffix": ""
                },
                {
                    "first": "V.I.",
                    "middle": [],
                    "last": "Saloutin",
                    "suffix": ""
                },
                {
                    "first": "G.G.",
                    "middle": [],
                    "last": "Aleksandrov",
                    "suffix": ""
                },
                {
                    "first": "O.N.",
                    "middle": [],
                    "last": "Chupakhin",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Russ. J. Org. Chem.",
            "volume": "36",
            "issn": "",
            "pages": "887-899",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF45": {
            "title": "Synthesis and antimicrobial activity of novel pyrazolo[3,4-b]quinoline derivatives",
            "authors": [
                {
                    "first": "O.A.",
                    "middle": [],
                    "last": "El-Sayed",
                    "suffix": ""
                },
                {
                    "first": "H.Y.",
                    "middle": [],
                    "last": "Aboul-Enein",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Arch. Pharm. Pharm. Med. Chem.",
            "volume": "334",
            "issn": "",
            "pages": "117-120",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF46": {
            "title": "Synthesis of thiazole, triazole, pyrazolo[3,4-b]-pyridinyl-3-phenylthiourea, aminopyrazolo[3,4-b]pyridine derivatives and their biological evaluation",
            "authors": [
                {
                    "first": "M.A.A.",
                    "middle": [],
                    "last": "Elneairy",
                    "suffix": ""
                },
                {
                    "first": "F.A.",
                    "middle": [],
                    "last": "Attaby",
                    "suffix": ""
                },
                {
                    "first": "M.S.",
                    "middle": [],
                    "last": "Elsayed",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Phosphorus Sulfur Silicon Relat. Elem.",
            "volume": "167",
            "issn": "",
            "pages": "161-179",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF47": {
            "title": "Novel synthesis of pyrazolyloxothiazolidine derivatives",
            "authors": [
                {
                    "first": "A.A.",
                    "middle": [],
                    "last": "Hassan",
                    "suffix": ""
                },
                {
                    "first": "Y.R.",
                    "middle": [],
                    "last": "Ibrahim",
                    "suffix": ""
                },
                {
                    "first": "E.M.",
                    "middle": [],
                    "last": "El-Sheref",
                    "suffix": ""
                },
                {
                    "first": "A.A.",
                    "middle": [],
                    "last": "Aly",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Braese",
                    "suffix": ""
                },
                {
                    "first": "A.B.",
                    "middle": [],
                    "last": "Brown",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "J.\u00a0Heterocycl. Chem.",
            "volume": "49",
            "issn": "",
            "pages": "1380-1385",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF48": {
            "title": "Synthesis of some sulfonamides, disubstituted sulfonylureas or thioureas and some structurally related variants. A class of promising antitumor agents",
            "authors": [
                {
                    "first": "H.M.",
                    "middle": [],
                    "last": "Faidallah",
                    "suffix": ""
                },
                {
                    "first": "M.S.",
                    "middle": [],
                    "last": "Al-Saadi",
                    "suffix": ""
                },
                {
                    "first": "S.A.F.",
                    "middle": [],
                    "last": "Rostom",
                    "suffix": ""
                },
                {
                    "first": "H.T.Y.",
                    "middle": [],
                    "last": "Fahmy",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Med. Chem. Res.",
            "volume": "16",
            "issn": "",
            "pages": "300-318",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF49": {
            "title": "Synthesis and in\u00a0vitro antitumor and antimicrobial activity of some 2,3-diaryl-7-methyl-4,5,6,7-tetrahydroindazole and 3,3a,4,5,6,7-hexahydroindazole derivatives",
            "authors": [
                {
                    "first": "H.M.",
                    "middle": [],
                    "last": "Faidallah",
                    "suffix": ""
                },
                {
                    "first": "K.A.",
                    "middle": [],
                    "last": "Khan",
                    "suffix": ""
                },
                {
                    "first": "S.A.F.",
                    "middle": [],
                    "last": "Rostom",
                    "suffix": ""
                },
                {
                    "first": "A.M.",
                    "middle": [],
                    "last": "Asiri",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "J.\u00a0Enzym. Inhib. Med. Chem.",
            "volume": "28",
            "issn": "",
            "pages": "495-508",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF50": {
            "title": "4-Thiazolidones: centenarian history, current status and perspectives for modern organic and medicinal chemistry",
            "authors": [
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Lesyk",
                    "suffix": ""
                },
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Zimenkovsky",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Curr. Org. Chem.",
            "volume": "8",
            "issn": "",
            "pages": "1547-1577",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF51": {
            "title": "3-Methyl-2-(4-substituted phenyl)-4,5-dihydronaphtho[1,2-c]-pyrazoles: synthesis and in-vitro biological evaluation as antitumour agents",
            "authors": [
                {
                    "first": "M.S.",
                    "middle": [],
                    "last": "Al-Saadi",
                    "suffix": ""
                },
                {
                    "first": "S.A.F.",
                    "middle": [],
                    "last": "Rostom",
                    "suffix": ""
                },
                {
                    "first": "H.M.",
                    "middle": [],
                    "last": "Faidallah",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Arch. Pharm. Chem. Life Sci.",
            "volume": "341",
            "issn": "",
            "pages": "181-190",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF52": {
            "title": "Synthesis and in\u00a0vitro antitumor evaluation of some indeno[1,2-c]pyrazol(in)es substituted with sulfonamide, sulfonylurea(-thiourea) pharmacophores, and some derived thiazole ring systems",
            "authors": [
                {
                    "first": "S.A.F.",
                    "middle": [],
                    "last": "Rostom",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Bioorg. Med. Chem.",
            "volume": "14",
            "issn": "",
            "pages": "6475-6485",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF53": {
            "title": "Synthesis and biological evaluation of new 3- trifluoromethylpyrazolesulfonyl-urea and thiourea derivatives as antidiabetic and antimicrobial agents",
            "authors": [
                {
                    "first": "H.M.",
                    "middle": [],
                    "last": "Faidallah",
                    "suffix": ""
                },
                {
                    "first": "K.A.",
                    "middle": [],
                    "last": "Khan",
                    "suffix": ""
                },
                {
                    "first": "A.M.",
                    "middle": [],
                    "last": "Asiri",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "J.\u00a0Fluor. Chem.",
            "volume": "132",
            "issn": "",
            "pages": "131-137",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF54": {
            "title": "Synthesis and biological evaluation of some new bipyrazolylbenzenesulfonamides as possible antimicrobial and chemotherapeutic agents",
            "authors": [
                {
                    "first": "H.M.",
                    "middle": [],
                    "last": "Faidallah",
                    "suffix": ""
                },
                {
                    "first": "K.A.",
                    "middle": [],
                    "last": "Khan",
                    "suffix": ""
                },
                {
                    "first": "A.M.",
                    "middle": [],
                    "last": "Asiri",
                    "suffix": ""
                },
                {
                    "first": "M.E.M.",
                    "middle": [],
                    "last": "Zayed",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Indian J. Chem. B",
            "volume": "51",
            "issn": "",
            "pages": "1114-1122",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF55": {
            "title": "An efficient two-step synthesis of novel thiazolo[2,3-b]pyrazolo[3,4-f][1, 3,5]triazepines",
            "authors": [
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Insuasty",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Tigreros",
                    "suffix": ""
                },
                {
                    "first": "H.",
                    "middle": [],
                    "last": "Martinez",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Quiroga",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Abonia",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Gutierrez",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Nogueras",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Cobo",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "J.\u00a0Heterocycl. Chem.",
            "volume": "46",
            "issn": "",
            "pages": "756-761",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF56": {
            "title": "Synthesis and cytotoxicity screening of some novel benzofuranoyl-pyrazole derivatives against liver and cervix carcinoma cell lines",
            "authors": [
                {
                    "first": "M.I.",
                    "middle": [],
                    "last": "El-Zahar",
                    "suffix": ""
                },
                {
                    "first": "S.S.",
                    "middle": [],
                    "last": "Abd El-Karim",
                    "suffix": ""
                },
                {
                    "first": "M.M.",
                    "middle": [],
                    "last": "Anwar",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "S.\u00a0Afr. J. Chem.",
            "volume": "62",
            "issn": "",
            "pages": "189-199",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF57": {
            "title": "Synthesis and biological evaluation of some thiazolyl and thiadiazolyl derivatives of 1H-pyrazole as anti-inflammatory antimicrobial agents",
            "authors": [
                {
                    "first": "A.A.",
                    "middle": [],
                    "last": "Bekhit",
                    "suffix": ""
                },
                {
                    "first": "H.M.A.",
                    "middle": [],
                    "last": "Ashour",
                    "suffix": ""
                },
                {
                    "first": "Y.S.",
                    "middle": [],
                    "last": "Abdel Ghany",
                    "suffix": ""
                },
                {
                    "first": "A.E.-D.A.",
                    "middle": [],
                    "last": "Bekhit",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Baraka",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Eur. J. Med. Chem.",
            "volume": "43",
            "issn": "",
            "pages": "456-463",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF58": {
            "title": "A\u00a0convenient route to 1,3,4-thiadiazoles, thiazolidinone, thiazoles, pyridones, coumarins, triazolo[5,1-c]triazines, and pyrazolo[5,1-c]triazines incorporating pyrazolone moiety and their use as antimicrobial agents",
            "authors": [
                {
                    "first": "M.M.",
                    "middle": [],
                    "last": "Abdelall",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Phosphorus Sulfur Silicon Relat. Elem.",
            "volume": "184",
            "issn": "",
            "pages": "2208-2226",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF59": {
            "title": "Synthesis, antimicrobial, antioxidant, anti-inflammatory, and analgesic activities of some new 3-(2-thienyl)pyrazole-based heterocycles",
            "authors": [
                {
                    "first": "B.F.",
                    "middle": [],
                    "last": "Abdel-Wahab",
                    "suffix": ""
                },
                {
                    "first": "H.",
                    "middle": [],
                    "last": "Abdel-Gawad",
                    "suffix": ""
                },
                {
                    "first": "G.E.A.",
                    "middle": [],
                    "last": "Awad",
                    "suffix": ""
                },
                {
                    "first": "F.A.",
                    "middle": [],
                    "last": "Badria",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Med. Chem. Res.",
            "volume": "21",
            "issn": "",
            "pages": "1418-1426",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF60": {
            "title": "Synthesis and antimicrobial activity of some new heterocycles based on 3-methyl-1-phenyl-5-benzene sulfonamido pyrazole",
            "authors": [
                {
                    "first": "T.I.",
                    "middle": [],
                    "last": "El-Emary",
                    "suffix": ""
                },
                {
                    "first": "N.",
                    "middle": [],
                    "last": "Al-Muaikel",
                    "suffix": ""
                },
                {
                    "first": "O.S.",
                    "middle": [],
                    "last": "Moustafa",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Phosphorus Sulfur Silicon Relat. Elem.",
            "volume": "177",
            "issn": "",
            "pages": "195-210",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF61": {
            "title": "Thiazolidinone motif in anticancer drug discovery. Experience of DH LNMU medicinal chemistry scientific group",
            "authors": [
                {
                    "first": "R.B.",
                    "middle": [],
                    "last": "Lesyk",
                    "suffix": ""
                },
                {
                    "first": "B.S.",
                    "middle": [],
                    "last": "Zimenkovsky",
                    "suffix": ""
                },
                {
                    "first": "D.V.",
                    "middle": [],
                    "last": "Kaminskyy",
                    "suffix": ""
                },
                {
                    "first": "A.P.",
                    "middle": [],
                    "last": "Kryshchyshyn",
                    "suffix": ""
                },
                {
                    "first": "D.Ya.",
                    "middle": [],
                    "last": "Havrylyuk",
                    "suffix": ""
                },
                {
                    "first": "D.V.",
                    "middle": [],
                    "last": "Atamanyuk",
                    "suffix": ""
                },
                {
                    "first": "I.Yu.",
                    "middle": [],
                    "last": "Subtel'na",
                    "suffix": ""
                },
                {
                    "first": "D.V.",
                    "middle": [],
                    "last": "Khyluk",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Biopolym. Cell",
            "volume": "27",
            "issn": "",
            "pages": "107-117",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF62": {
            "title": "Design and synthesis of some oxadiazolyl, thiadiazolyl, thiazolidinyl, and thiazolyl derivatives of 1H-pyrazole as anti-inflammatory antimicrobial agents",
            "authors": [
                {
                    "first": "A.A.",
                    "middle": [],
                    "last": "Farghaly",
                    "suffix": ""
                },
                {
                    "first": "A.A.",
                    "middle": [],
                    "last": "Bekhit",
                    "suffix": ""
                },
                {
                    "first": "J.Y.",
                    "middle": [],
                    "last": "Park",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Arch. Pharm. Pharm. Med. Chem.",
            "volume": "333",
            "issn": "",
            "pages": "53-57",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF63": {
            "title": "New pyrazole derivatives of potential biological activity",
            "authors": [
                {
                    "first": "A.-R.",
                    "middle": [],
                    "last": "Farghaly",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Esmail",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Abdel-Hafez",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Vanelle",
                    "suffix": ""
                },
                {
                    "first": "H.",
                    "middle": [],
                    "last": "El-Kashef",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Arkivoc",
            "volume": "7",
            "issn": "",
            "pages": "228-241",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF64": {
            "title": "Convenient synthesis and antimicrobial activity of new 3-substituted 5-(benzofuran-2-yl)-pyrazole derivatives",
            "authors": [
                {
                    "first": "B.F.",
                    "middle": [],
                    "last": "Abdel-Wahab",
                    "suffix": ""
                },
                {
                    "first": "H.A.",
                    "middle": [],
                    "last": "Abdel-Aziz",
                    "suffix": ""
                },
                {
                    "first": "E.M.",
                    "middle": [],
                    "last": "Ahmed",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Arch. Pharm. Chem. Life Sci.",
            "volume": "341",
            "issn": "",
            "pages": "734-739",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF65": {
            "title": "Cytotoxicity and utility of 1-indanone in the synthesis of some new heterocycles",
            "authors": [
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Hegazi",
                    "suffix": ""
                },
                {
                    "first": "H.A.",
                    "middle": [],
                    "last": "Mohamed",
                    "suffix": ""
                },
                {
                    "first": "K.M.",
                    "middle": [],
                    "last": "Dawood",
                    "suffix": ""
                },
                {
                    "first": "F.A.-R.",
                    "middle": [],
                    "last": "Badria",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Chem. Pharm. Bull.",
            "volume": "58",
            "issn": "",
            "pages": "479-483",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF66": {
            "title": "Synthesis, anti-HSV-1, and cytotoxic activities of some new pyrazole- and isoxazole-based heterocycles",
            "authors": [
                {
                    "first": "K.M.",
                    "middle": [],
                    "last": "Dawood",
                    "suffix": ""
                },
                {
                    "first": "H.",
                    "middle": [],
                    "last": "Abdel-Gawad",
                    "suffix": ""
                },
                {
                    "first": "H.A.",
                    "middle": [],
                    "last": "Mohamed",
                    "suffix": ""
                },
                {
                    "first": "F.A.",
                    "middle": [],
                    "last": "Badria",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Med. Chem. Res.",
            "volume": "20",
            "issn": "",
            "pages": "912-919",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF67": {
            "title": "The use of 3-amino-4,6-dimethylpyrazolo[3,4-b]pyridine in the synthesis of novel heterocycles of pharmaceutical interest",
            "authors": [
                {
                    "first": "M.A.",
                    "middle": [],
                    "last": "Metwally",
                    "suffix": ""
                },
                {
                    "first": "H.A.",
                    "middle": [],
                    "last": "Etman",
                    "suffix": ""
                },
                {
                    "first": "H.E.",
                    "middle": [],
                    "last": "Gafer",
                    "suffix": ""
                },
                {
                    "first": "A.M.",
                    "middle": [],
                    "last": "Khalil",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Chem. Heterocycl. Compd.",
            "volume": "44",
            "issn": "",
            "pages": "715-721",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF68": {
            "title": "Reaction of 3-phenyl-5-aminopyrazole with carbon disulfide: a novel synthesis of 3-(3\u2032-phenylpyrazol-5'-yl)-4-phenylpyrazol-2-thione as well as of pyrazolo[3,4-d]thiazole and pyrano[2,3-d]thiazole derivatives",
            "authors": [
                {
                    "first": "R.M.",
                    "middle": [],
                    "last": "Mohareb",
                    "suffix": ""
                },
                {
                    "first": "H.F.",
                    "middle": [],
                    "last": "Zohdi",
                    "suffix": ""
                },
                {
                    "first": "W.W.",
                    "middle": [],
                    "last": "Wardakhan",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "Monatsh. Chem.",
            "volume": "126",
            "issn": "",
            "pages": "1391-1400",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF69": {
            "title": "Synthesis and antitumor activity of some novel pyrazole and thienopyrimidine derivatives",
            "authors": [
                {
                    "first": "H.M.",
                    "middle": [],
                    "last": "Aly",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Phosphorus Sulfur Silicon Relat. Elem.",
            "volume": "185",
            "issn": "",
            "pages": "211-221",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF70": {
            "title": "Synthesis and biological evaluation of novel pyrazoles and pyrazolo[3,4-d]pyrimidines incorporating a benzenesulfonamide moiety",
            "authors": [
                {
                    "first": "H.M.A.",
                    "middle": [],
                    "last": "Ashour",
                    "suffix": ""
                },
                {
                    "first": "A.E.A.",
                    "middle": [],
                    "last": "Wahab",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Arch. Pharm. Chem. Life Sci.",
            "volume": "342",
            "issn": "",
            "pages": "238-252",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF71": {
            "title": "Synthesis and biological activity of 4\u2032-oxathiazolidinyl benzopyrazoles",
            "authors": [
                {
                    "first": "N.P.",
                    "middle": [],
                    "last": "Shetgiri",
                    "suffix": ""
                },
                {
                    "first": "A.D.",
                    "middle": [],
                    "last": "Chitre",
                    "suffix": ""
                },
                {
                    "first": "S.V.",
                    "middle": [],
                    "last": "Kokitkar",
                    "suffix": ""
                },
                {
                    "first": "S.M.",
                    "middle": [],
                    "last": "Ghate",
                    "suffix": ""
                },
                {
                    "first": "S.S.",
                    "middle": [],
                    "last": "Patil",
                    "suffix": ""
                },
                {
                    "first": "R.C.",
                    "middle": [],
                    "last": "Kelaskar",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Indian J. Chem. B",
            "volume": "45",
            "issn": "",
            "pages": "1308-1311",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF72": {
            "title": "Rhodanine as a privileged scaffold in drug discovery",
            "authors": [
                {
                    "first": "T.",
                    "middle": [],
                    "last": "Tomasich",
                    "suffix": ""
                },
                {
                    "first": "L.P.",
                    "middle": [],
                    "last": "Masich",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Curr. Med. Chem.",
            "volume": "16",
            "issn": "",
            "pages": "1596-1629",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF73": {
            "title": "Synthesis, antitubercular and antimicrobial evaluation of 3-(4-chlorophenyl)-4-substituted pyrazole derivatives",
            "authors": [
                {
                    "first": "R.B.",
                    "middle": [],
                    "last": "Pathak",
                    "suffix": ""
                },
                {
                    "first": "P.T.",
                    "middle": [],
                    "last": "Chovatia",
                    "suffix": ""
                },
                {
                    "first": "H.H.",
                    "middle": [],
                    "last": "Parekh",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Bioorg. Med. Chem. Lett.",
            "volume": "22",
            "issn": "",
            "pages": "5129-5133",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF74": {
            "title": "Rac-3-(5-amino-3-methyl-1-phenyl-1H-pyrazol-4-yl)-2-phenylthiazolidin-4-one: sheets built from N-H\u2026N and C-H\u2026pi(arene) hydrogen bonds",
            "authors": [
                {
                    "first": "J.N.",
                    "middle": [],
                    "last": "Low",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Cobo",
                    "suffix": ""
                },
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Insuasty",
                    "suffix": ""
                },
                {
                    "first": "F.",
                    "middle": [],
                    "last": "Orozco",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Glidewell",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Acta Crystallogr. C",
            "volume": "60",
            "issn": "",
            "pages": "o486-o488",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF75": {
            "title": "Synthesis and antimicrobial study of linked heterocyclics containing pyrazole-pyrimidine-thiazolidin-4-one",
            "authors": [
                {
                    "first": "C.S.",
                    "middle": [],
                    "last": "Reddy",
                    "suffix": ""
                },
                {
                    "first": "M.V.",
                    "middle": [],
                    "last": "Devi",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Sunitha",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Nagaraj",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Chem. Pharm. Bull.",
            "volume": "58",
            "issn": "",
            "pages": "1622-1626",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF76": {
            "title": "Novel fluorinated spiro [indole-indazolyl-thiazolidine]-2,4\u2032-diones: design and synthesis",
            "authors": [
                {
                    "first": "S.C.",
                    "middle": [],
                    "last": "Jain",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Khanna",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Bhagat",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Jain",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Sakhuja",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Phosphorus Sulfur Silicon Relat. Elem.",
            "volume": "180",
            "issn": "",
            "pages": "1829-1839",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF77": {
            "title": "Synthesis and pharmacological studies of some phthalimidoxy substituted spiro-thiazolidinone derivatives of isatin",
            "authors": [
                {
                    "first": "D.",
                    "middle": [],
                    "last": "Bhambi",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Sharma",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Sharma",
                    "suffix": ""
                },
                {
                    "first": "V.K.",
                    "middle": [],
                    "last": "Salvi",
                    "suffix": ""
                },
                {
                    "first": "G.L.",
                    "middle": [],
                    "last": "Talesara",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Indian J. Chem. B",
            "volume": "48",
            "issn": "",
            "pages": "1006-1012",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF78": {
            "title": "Synthese substituierter rhodanine",
            "authors": [
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Augustin",
                    "suffix": ""
                },
                {
                    "first": "W.-D.",
                    "middle": [],
                    "last": "Rudorf",
                    "suffix": ""
                }
            ],
            "year": 1974,
            "venue": "J.\u00a0Prakt. Chem.",
            "volume": "316",
            "issn": "",
            "pages": "520-524",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF79": {
            "title": "Synthesis and in\u00a0vivo anticancer and antiangiogenic effects of novel thioxothiazolidin-4-one derivatives against transplantable mouse tumor",
            "authors": [
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Chandrappa",
                    "suffix": ""
                },
                {
                    "first": "H.",
                    "middle": [],
                    "last": "Chandru",
                    "suffix": ""
                },
                {
                    "first": "A.C.",
                    "middle": [],
                    "last": "Sharada",
                    "suffix": ""
                },
                {
                    "first": "K.",
                    "middle": [],
                    "last": "Vinaya",
                    "suffix": ""
                },
                {
                    "first": "C.S.A.",
                    "middle": [],
                    "last": "Kumar",
                    "suffix": ""
                },
                {
                    "first": "N.R.",
                    "middle": [],
                    "last": "Thimmegowda",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Nagegowda",
                    "suffix": ""
                },
                {
                    "first": "M.K.",
                    "middle": [],
                    "last": "Kumar",
                    "suffix": ""
                },
                {
                    "first": "K.S.",
                    "middle": [],
                    "last": "Rangappa",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Med. Chem. Res.",
            "volume": "19",
            "issn": "",
            "pages": "236-249",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF80": {
            "title": "Synthesis of new 4-azolidinones with 3,5-diaryl-4,5-dihydropyrazole moiety and evaluation of their antitumor activity in\u00a0vitro",
            "authors": [
                {
                    "first": "D.",
                    "middle": [],
                    "last": "Havrylyuk",
                    "suffix": ""
                },
                {
                    "first": "N.",
                    "middle": [],
                    "last": "Kovach",
                    "suffix": ""
                },
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Zimenkovsky",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Lesyk",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Ann. Univ. Mariae Curie-Sklodowska",
            "volume": "23",
            "issn": "",
            "pages": "173-177",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF81": {
            "title": "Dicationic ionic liquid mediated synthesis of 5-arylidine-2,4-thiazolidinediones",
            "authors": [
                {
                    "first": "D.V.",
                    "middle": [],
                    "last": "Jawale",
                    "suffix": ""
                },
                {
                    "first": "D.L.",
                    "middle": [],
                    "last": "Lingampalle",
                    "suffix": ""
                },
                {
                    "first": "R.A.",
                    "middle": [],
                    "last": "Mane",
                    "suffix": ""
                },
                {
                    "first": "U.R.",
                    "middle": [],
                    "last": "Pratap",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Chin. J. Chem.",
            "volume": "29",
            "issn": "",
            "pages": "942-946",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF82": {
            "title": "Synthesis and biological evaluation of novel pyrazolyl-2,4-thiazolidinediones as anti-inflammatory and neuroprotective agents",
            "authors": [
                {
                    "first": "A.M.",
                    "middle": [],
                    "last": "Youssef",
                    "suffix": ""
                },
                {
                    "first": "M.S.",
                    "middle": [],
                    "last": "White",
                    "suffix": ""
                },
                {
                    "first": "E.B.",
                    "middle": [],
                    "last": "Villanueva",
                    "suffix": ""
                },
                {
                    "first": "I.M.",
                    "middle": [],
                    "last": "El-Ashmawy",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Klegeris",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Bioorg. Med. Chem.",
            "volume": "18",
            "issn": "",
            "pages": "2019-2028",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF83": {
            "title": "4-Thiazolidinone - a biologically active scaffold",
            "authors": [
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Verma",
                    "suffix": ""
                },
                {
                    "first": "S.K.",
                    "middle": [],
                    "last": "Saraf",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Eur. J. Med. Chem.",
            "volume": "43",
            "issn": "",
            "pages": "897-905",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF84": {
            "title": "Synthesis and antimicrobial activity of some new of 5-((3-(aryl)-1-phenyl-1H-pyrazol-4-yl)methylene)-3-phenylthiazolidine-2,4-diones",
            "authors": [
                {
                    "first": "O.",
                    "middle": [],
                    "last": "Prakash",
                    "suffix": ""
                },
                {
                    "first": "D.K.",
                    "middle": [],
                    "last": "Aneja",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Arora",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Sharma",
                    "suffix": ""
                },
                {
                    "first": "K.R.",
                    "middle": [],
                    "last": "Aneja",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Med. Chem. Res.",
            "volume": "21",
            "issn": "",
            "pages": "10-15",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF85": {
            "title": "Synthesis and antimicrobial activity of 5-((3-aryl-1-phenyl-1H-pyrazol-4-yl)methylene)thiazolidine-2,4-diones",
            "authors": [
                {
                    "first": "O.",
                    "middle": [],
                    "last": "Prakash",
                    "suffix": ""
                },
                {
                    "first": "D.K.",
                    "middle": [],
                    "last": "Aneja",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Lohan",
                    "suffix": ""
                },
                {
                    "first": "K.",
                    "middle": [],
                    "last": "Hussain",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Arora",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Sharma",
                    "suffix": ""
                },
                {
                    "first": "K.R.",
                    "middle": [],
                    "last": "Aneja",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Med. Chem. Res.",
            "volume": "21",
            "issn": "",
            "pages": "2961-2968",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF86": {
            "title": "Synthesis, antifungal and antitumor activity of novel (Z)-5-hetarylmethylidene-1,3-thiazol-4-ones and (Z)-5-ethylidene-1,3-thiazol-4-ones",
            "authors": [
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Insuasty",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Ramirez",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Raimondi",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Echeverry",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Quiroga",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Abonia",
                    "suffix": ""
                },
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Nogueras",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Cobo",
                    "suffix": ""
                },
                {
                    "first": "M.V.",
                    "middle": [],
                    "last": "Rodriguez",
                    "suffix": ""
                },
                {
                    "first": "S.A.",
                    "middle": [],
                    "last": "Zacchino",
                    "suffix": ""
                },
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Insuasty",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Molecules",
            "volume": "18",
            "issn": "",
            "pages": "5482-5497",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF87": {
            "title": "5-((1H-Pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one inhibitors of ADAMTS-5",
            "authors": [
                {
                    "first": "A.M.",
                    "middle": [],
                    "last": "Gilbert",
                    "suffix": ""
                },
                {
                    "first": "M.G.",
                    "middle": [],
                    "last": "Bursavich",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Lombardi",
                    "suffix": ""
                },
                {
                    "first": "K.E.",
                    "middle": [],
                    "last": "Georgiadis",
                    "suffix": ""
                },
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Reifenberg",
                    "suffix": ""
                },
                {
                    "first": "C.R.",
                    "middle": [],
                    "last": "Flannery",
                    "suffix": ""
                },
                {
                    "first": "E.A.",
                    "middle": [],
                    "last": "Morris",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Bioorg. Med. Chem. Lett.",
            "volume": "17",
            "issn": "",
            "pages": "1189-1192",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF88": {
            "title": "Synthesis and antimicrobial activity of some new N-glycosides of 2-thioxo-4-thiazolidinone derivatives",
            "authors": [
                {
                    "first": "N.H.",
                    "middle": [],
                    "last": "Metwally",
                    "suffix": ""
                },
                {
                    "first": "M.A.",
                    "middle": [],
                    "last": "Abdalla",
                    "suffix": ""
                },
                {
                    "first": "M.A.N.",
                    "middle": [],
                    "last": "Mosselhi",
                    "suffix": ""
                },
                {
                    "first": "E.A.",
                    "middle": [],
                    "last": "El-Desoky",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Carbohydr. Res.",
            "volume": "345",
            "issn": "",
            "pages": "1135-1141",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF89": {
            "title": "Synthesis and biological evaluation of 5-aryloxypyrazole derivatives bearing a rhodanine-3-aromatic acid as potential antimicrobial agents",
            "authors": [
                {
                    "first": "C.-J.",
                    "middle": [],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "M.-X.",
                    "middle": [],
                    "last": "Song",
                    "suffix": ""
                },
                {
                    "first": "L.-P.",
                    "middle": [],
                    "last": "Sun",
                    "suffix": ""
                },
                {
                    "first": "Y.",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Hong",
                    "suffix": ""
                },
                {
                    "first": "H.-R.",
                    "middle": [],
                    "last": "Piao",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Bioorg. Med. Chem. Lett.",
            "volume": "22",
            "issn": "",
            "pages": "7024-7028",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF90": {
            "title": "Synthesis and antibacterial activity of novel 1,3-diphenyl-1H-pyrazoles functionalized with phenylalanine-derived rhodanines",
            "authors": [
                {
                    "first": "C.-J.",
                    "middle": [],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "L.-L.",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "L.-P.",
                    "middle": [],
                    "last": "Sun",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Miao",
                    "suffix": ""
                },
                {
                    "first": "H.-R.",
                    "middle": [],
                    "last": "Piao",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Eur. J. Med. Chem.",
            "volume": "58",
            "issn": "",
            "pages": "112-116",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF91": {
            "title": "Structure-activity relationship study of a novel necroptosis inhibitor, Necrostatin-7",
            "authors": [
                {
                    "first": "W.",
                    "middle": [],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Degterev",
                    "suffix": ""
                },
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Hsu",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Yuan",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Yuan",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Bioorg. Med. Chem. Lett.",
            "volume": "18",
            "issn": "",
            "pages": "4932-4935",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF92": {
            "title": "Synthesis and antimicrobial evaluation of some novel 2-(4-chlorophenylimino)thiazolidin-4-one derivatives",
            "authors": [
                {
                    "first": "H.",
                    "middle": [],
                    "last": "B'Bhatt",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Sharma",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "J.\u00a0Korean Chem. Soc.",
            "volume": "56",
            "issn": "",
            "pages": "341-347",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF93": {
            "title": "Synthesis, antimicrobial, antioxidant, anti-hemolytic and cytotoxic evaluation of new imidazole-based heterocycles",
            "authors": [
                {
                    "first": "B.F.",
                    "middle": [],
                    "last": "Abdel-Wahab",
                    "suffix": ""
                },
                {
                    "first": "G.E.A.",
                    "middle": [],
                    "last": "Awad",
                    "suffix": ""
                },
                {
                    "first": "F.A.",
                    "middle": [],
                    "last": "Badria",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Eur. J. Med. Chem.",
            "volume": "46",
            "issn": "",
            "pages": "1505-1511",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF94": {
            "title": "Chemisry and biological activities of 1,3-thiazolidin-4-ones",
            "authors": [
                {
                    "first": "W.",
                    "middle": [],
                    "last": "Cunico",
                    "suffix": ""
                },
                {
                    "first": "C.R.B.",
                    "middle": [],
                    "last": "Gomes",
                    "suffix": ""
                },
                {
                    "first": "W.T.",
                    "middle": [],
                    "last": "Vellasco",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Mini Rev. Org. Chem.",
            "volume": "5",
            "issn": "",
            "pages": "336-344",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF95": {
            "title": "Studies on 2-pyrazolin-5-one derivatives",
            "authors": [
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Mitra",
                    "suffix": ""
                },
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Nayak",
                    "suffix": ""
                },
                {
                    "first": "A.S.",
                    "middle": [],
                    "last": "Mittra",
                    "suffix": ""
                }
            ],
            "year": 1982,
            "venue": "J.\u00a0Indian Chem. Soc.",
            "volume": "59",
            "issn": "",
            "pages": "1005-1007",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF96": {
            "title": "Synthesis of new azocompounds and fused pyrazolo[5,1-c][1,2,4]triazines using heterocyclic components",
            "authors": [
                {
                    "first": "I.V.",
                    "middle": [],
                    "last": "Ledenyova",
                    "suffix": ""
                },
                {
                    "first": "V.V.",
                    "middle": [],
                    "last": "Didenko",
                    "suffix": ""
                },
                {
                    "first": "A.S.",
                    "middle": [],
                    "last": "Shestakov",
                    "suffix": ""
                },
                {
                    "first": "K.S.",
                    "middle": [],
                    "last": "Shikhaliev",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "J.\u00a0Heterocycl. Chem.",
            "volume": "50",
            "issn": "",
            "pages": "573-578",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF97": {
            "title": "Synthesis and anticancer activity of isatin-based pyrazolines and thiazolidines conjugates",
            "authors": [
                {
                    "first": "D.",
                    "middle": [],
                    "last": "Havrylyuk",
                    "suffix": ""
                },
                {
                    "first": "N.",
                    "middle": [],
                    "last": "Kovach",
                    "suffix": ""
                },
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Zimenkovsky",
                    "suffix": ""
                },
                {
                    "first": "O.",
                    "middle": [],
                    "last": "Vasylenko",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Lesyk",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Arch. Pharm. Chem. Life Sci.",
            "volume": "344",
            "issn": "",
            "pages": "514-522",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF98": {
            "title": "Synthesis and biological activity of 4-(3-aryl-4-oxo-2-thioxothiazolidin-5-ylimino)-3-methyl-1-(N,N-disubstituted aminomethyl)pyrazolin-5-ones",
            "authors": [
                {
                    "first": "M.I.",
                    "middle": [],
                    "last": "Husain",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Shukla",
                    "suffix": ""
                }
            ],
            "year": 1986,
            "venue": "Indian J. Chem.",
            "volume": "25B",
            "issn": "",
            "pages": "983-985",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF99": {
            "title": "A\u00a0new approach for the synthesis of bioactive heteroaryl thiazolidine-2,4-diones",
            "authors": [
                {
                    "first": "M.A.",
                    "middle": [],
                    "last": "Ibrahim",
                    "suffix": ""
                },
                {
                    "first": "M.A.-M.",
                    "middle": [],
                    "last": "Abdel-Hamed",
                    "suffix": ""
                },
                {
                    "first": "N.M.",
                    "middle": [],
                    "last": "El-Gohary",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "J.\u00a0Braz. Chem. Soc.",
            "volume": "22",
            "issn": "",
            "pages": "1130-1139",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF100": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF101": {
            "title": "Syntheis and fungitoxicity of some bicyclic compounds",
            "authors": [
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Mittra",
                    "suffix": ""
                },
                {
                    "first": "A.S.",
                    "middle": [],
                    "last": "Mittra",
                    "suffix": ""
                }
            ],
            "year": 1981,
            "venue": "J.\u00a0Indian Chem. Soc.",
            "volume": "58",
            "issn": "",
            "pages": "923-925",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF102": {
            "title": "Synthesis and biological activity evaluation of 5-pyrazoline substituted 4-thiazolidinones",
            "authors": [
                {
                    "first": "D.",
                    "middle": [],
                    "last": "Havrylyuk",
                    "suffix": ""
                },
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Zimenkovsky",
                    "suffix": ""
                },
                {
                    "first": "O.",
                    "middle": [],
                    "last": "Vasylenko",
                    "suffix": ""
                },
                {
                    "first": "C.W.",
                    "middle": [],
                    "last": "Day",
                    "suffix": ""
                },
                {
                    "first": "D.F.",
                    "middle": [],
                    "last": "Smee",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Grellier",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Lesyk",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Eur. J. Med. Chem.",
            "volume": "66",
            "issn": "",
            "pages": "228-237",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF103": {
            "title": "Synthesis of pyrazoline-thiazolidinone hybrids with trypanocidal activity",
            "authors": [
                {
                    "first": "D.",
                    "middle": [],
                    "last": "Havrylyuk",
                    "suffix": ""
                },
                {
                    "first": "B.",
                    "middle": [],
                    "last": "Zimenkovsky",
                    "suffix": ""
                },
                {
                    "first": "O.",
                    "middle": [],
                    "last": "Karpenko",
                    "suffix": ""
                },
                {
                    "first": "P.",
                    "middle": [],
                    "last": "Grellier",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Lesyk",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Eur. J. Med. Chem.",
            "volume": "85",
            "issn": "",
            "pages": "245-254",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF104": {
            "title": "Design and synthesis of novel bis-thiazolone derivatives as micromolar CDC25 phosphatase inhibitors: effect of dimerisation on phosphatase inhibition",
            "authors": [
                {
                    "first": "M.",
                    "middle": [],
                    "last": "Sarkis",
                    "suffix": ""
                },
                {
                    "first": "D.N.",
                    "middle": [],
                    "last": "Tran",
                    "suffix": ""
                },
                {
                    "first": "M.A.",
                    "middle": [],
                    "last": "Miteva",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Kolb",
                    "suffix": ""
                },
                {
                    "first": "B.O.",
                    "middle": [],
                    "last": "Villoutreix",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Garbay",
                    "suffix": ""
                },
                {
                    "first": "E.",
                    "middle": [],
                    "last": "Braud",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Bioorg. Med. Chem. Lett.",
            "volume": "22",
            "issn": "",
            "pages": "7345-7350",
            "other_ids": {
                "DOI": []
            }
        }
    }
}